rfhg_167682.1

Basic information about the TSS

---

TSS ID: rfhg_167682.1 Species: human Chr: chr14		Start: 69769479 End: 69769490 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF070562:60 GeneID: 6430 HGNC/MGI_ID: HGNC:10787 UniProt_ID: Nearer transcript ids and distances:

Gene_name: LOC100289511 Gene_symbol: SRSF5 Gene_synonyms: HRS SRP40 Gene_source: HGNC:10787

TATA-Box annotation

---

Distance to TSS:	-1771
Nearest PromoterID:	NR_029378
Entrez ID:	100289511
Nearest Unigene:	Hs.729250
Nearest Refseq:	NR_029378
Nearest Ensembl:
Gene Name:	LOC100289511
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.166667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SRSF5 p2@SRSF5 p3@SRSF5 p4@SRSF5 p5@SRSF5 p6@SRSF5 p7@SRSF5 p10@SRSF5
Sample		p1@SRSF5	p2@SRSF5	p3@SRSF5	p4@SRSF5	p5@SRSF5	p6@SRSF5	p7@SRSF5	p10@SRSF5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	223.24	2.73	0.78	3.12	3.31	0.00	0.58	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	214.46	4.86	1.42	3.03	2.43	1.21	1.42	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	223.77	4.24	0.96	3.67	3.47	0.77	0.58	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	193.98	3.12	1.04	2.70	2.70	0.42	0.83	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	228.57	2.70	1.35	1.80	3.15	0.67	0.67	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	198.07	5.81	1.55	0.78	2.71	1.36	1.55	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	184.55	2.83	3.27	4.79	2.40	0.65	0.65	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	162.04	2.91	1.45	1.94	2.91	0.73	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	147.46	1.71	1.92	2.56	1.50	0.64	1.07	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	132.73	2.32	2.32	4.06	0.58	0.58	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	135.82	1.21	2.83	2.02	4.85	0.40	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	148.80	1.22	0.81	1.22	1.63	1.22	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	188.43	0.16	2.74	4.67	4.19	1.61	2.58	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	176.96	0.15	3.31	4.06	3.61	1.95	2.56	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	188.16	0.44	3.95	4.61	4.17	2.20	2.42	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	154.92	1.01	4.28	3.52	2.77	1.01	1.51	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	157.47	0.22	2.84	1.75	1.53	1.53	1.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	128.23	0.00	2.95	5.48	2.11	3.37	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	175.94	0.53	3.20	3.20	2.67	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	199.49	0.45	1.20	3.76	4.81	1.96	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	197.27	0.53	2.14	3.34	3.61	1.74	1.47	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	213.36	1.38	1.73	3.45	3.11	1.21	1.21	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	199.70	0.90	2.33	2.46	2.71	1.03	0.39	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	207.24	0.24	3.40	3.15	3.40	2.18	1.94	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	228.32	0.52	3.10	4.13	2.58	0.77	1.29	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	208.58	1.90	2.53	3.80	1.90	0.00	0.00	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	209.34	0.55	2.20	1.65	3.30	1.65	2.20	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	232.92	0.94	3.30	2.36	2.36	1.89	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	190.76	1.45	2.10	3.23	2.26	1.29	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	233.26	0.90	2.17	1.81	2.35	1.99	0.54	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	189.87	1.67	5.65	3.14	3.98	1.67	1.26	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	202.02	1.37	3.13	3.91	3.52	0.98	0.98	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	182.96	1.27	7.60	5.49	4.22	1.06	3.80	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	293.76	1.65	6.43	4.62	6.76	2.14	1.65	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	228.13	1.31	2.62	3.74	4.49	1.87	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	206.95	1.53	5.75	3.45	2.11	1.72	2.87	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	190.69	1.64	3.07	7.56	4.29	1.43	1.64	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	173.48	0.81	5.64	1.81	2.22	1.01	1.01	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	198.53	1.08	7.56	4.86	2.97	2.70	1.35	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	191.81	1.44	7.68	4.32	3.60	1.20	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	181.62	0.71	7.06	3.76	3.76	2.12	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	224.42	1.61	7.32	2.93	4.68	1.02	0.88	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	189.38	0.63	5.27	4.01	4.22	2.53	2.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	176.05	0.87	5.24	4.02	2.97	2.27	1.57	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	206.60	1.20	9.03	4.82	5.22	0.60	2.41	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	178.67	1.16	7.44	5.82	6.28	3.26	2.56	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	150.42	0.24	6.48	5.52	3.36	2.64	2.88	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	164.82	0.30	6.26	3.58	1.79	1.79	0.89	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	173.55	1.44	6.70	1.91	2.15	1.68	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	181.17	1.01	3.84	2.22	3.03	2.22	1.62	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	144.08	0.82	3.69	5.53	3.07	2.05	3.28	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	162.56	1.11	3.78	7.12	7.56	1.56	4.67	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	5205.09	27.98	55.97	13.99	13.99	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	120.65	0.35	3.90	6.39	2.13	1.42	5.32	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	135.20	0.33	2.32	6.30	2.65	1.33	1.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	944.64	10.07	10.91	8.39	15.10	9.23	2.52	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	266.82	1.38	7.35	5.05	6.43	0.46	2.76	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	143.26	0.32	4.21	8.75	2.92	1.94	8.10	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	124.61	0.64	3.85	8.35	2.57	1.93	5.46	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	232.29	0.31	2.83	5.34	6.60	1.89	1.26	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	117.04	0.71	5.64	4.23	4.23	1.41	4.23	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	127.30	0.56	2.80	6.17	2.24	2.24	2.80	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	393.29	7.96	7.96	8.76	30.25	16.72	3.98	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	190.61	1.02	2.72	7.47	6.46	1.36	5.10	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	133.87	0.65	4.55	7.80	3.25	2.27	9.42	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	106.14	0.71	3.90	4.97	2.84	2.13	2.48	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	3814.69	0.00	16.16	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	4193.56	0.00	23.69	15.79	7.90	7.90	7.90	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	105.79	0.98	1.46	6.34	4.39	1.46	7.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	102.15	0.00	3.47	1.49	2.48	0.00	3.97	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	104.61	0.47	1.88	2.81	1.41	1.41	2.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	190.76	0.99	2.98	6.29	6.62	1.99	7.29	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	108.27	0.31	6.19	6.81	1.55	1.24	8.04	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	112.51	0.00	5.50	4.28	2.14	0.61	7.34	0.31
Adipocyte - breast, donor1	11376-118A8	104.85	0.79	1.90	1.11	0.63	1.27	0.16	0.48
Adipocyte - breast, donor2	11327-117E4	104.60	1.12	3.69	1.44	1.44	2.09	0.48	0.32
Adipocyte - omental, donor1	11473-119C6	146.31	1.65	2.16	2.04	0.76	0.89	0.64	0.25
Adipocyte - omental, donor2	11474-119C7	72.51	2.24	11.21	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	96.79	0.33	9.71	1.34	0.67	0.67	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	105.91	0.64	7.66	0.64	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	57.17	0.00	0.00	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	71.81	0.90	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	93.67	0.70	0.17	0.17	0.17	0.17	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	202.22	0.39	1.56	1.17	0.39	1.37	0.78	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	184.54	0.26	2.57	1.03	1.80	0.77	2.32	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	147.19	0.28	1.95	1.95	0.56	0.28	0.56	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	191.63	0.00	2.94	2.35	1.18	1.18	3.53	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	258.03	1.37	1.85	1.69	0.64	1.29	0.80	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	217.54	1.29	3.55	2.90	1.61	0.97	6.78	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	192.48	0.00	2.67	1.60	1.60	1.07	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	140.22	0.56	5.01	1.11	0.56	0.00	3.90	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	164.69	1.66	5.82	2.08	1.66	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	179.58	0.00	3.01	1.51	1.51	1.26	2.26	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	142.68	0.65	1.64	1.96	1.31	0.33	1.96	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	122.09	0.91	1.22	2.44	0.91	0.30	3.04	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	56.58	0.22	0.22	0.22	0.22	0.00	0.00	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	26.54	0.00	0.36	0.00	0.00	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	0.00	0.00	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	83.12	0.00	0.54	0.72	0.72	0.18	0.18	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	55.23	0.00	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	62.46	0.00	0.41	0.21	0.00	0.21	0.00	0.82
Anulus Pulposus Cell, donor1	11248-116E6	225.65	1.26	0.34	0.23	0.23	0.46	0.00	0.92
Anulus Pulposus Cell, donor2	11463-119B5	153.80	1.96	1.22	0.00	0.24	0.24	0.00	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	138.83	1.80	1.80	0.00	0.45	1.35	0.00	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	141.10	2.17	3.91	0.00	0.00	0.00	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	94.17	2.14	0.00	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	141.99	2.69	0.90	0.90	0.60	0.60	1.20	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	135.32	0.00	1.26	2.53	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	95.05	0.00	1.32	1.98	1.32	0.00	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	137.43	1.62	1.30	0.65	0.65	0.00	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	164.08	3.88	3.88	1.46	0.97	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	98.58	0.59	0.59	1.19	4.16	2.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	148.39	3.39	0.75	0.00	0.75	1.51	0.38	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	151.67	3.63	3.63	1.45	0.73	0.73	0.00	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	104.06	2.51	0.00	0.00	0.00	2.51	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	162.10	3.29	0.66	0.00	0.33	0.66	0.00	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	162.41	0.00	0.00	0.00	0.00	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	142.80	1.96	0.90	0.90	0.45	0.00	0.30	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	149.48	1.61	4.29	2.14	1.61	0.00	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	153.98	2.08	3.59	0.76	0.38	0.76	0.76	1.70
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	150.75	2.94	1.87	0.53	0.53	1.07	0.53	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	110.23	0.98	1.95	0.00	0.98	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	143.14	2.49	3.15	1.16	0.50	1.66	0.33	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	99.66	3.60	7.20	3.60	6.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	77.88	3.54	0.00	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	115.95	1.72	5.15	1.20	0.86	0.51	0.69	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	62.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	96.60	0.00	4.85	1.46	0.97	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	109.28	3.04	3.42	0.38	0.76	0.00	0.00	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	82.37	1.21	2.42	0.00	1.21	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	102.61	3.42	3.42	0.57	0.57	2.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	87.65	0.43	5.56	0.64	0.43	0.21	0.43	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	67.88	0.26	2.06	1.81	1.55	0.77	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	124.81	1.88	0.47	1.41	0.47	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	127.98	0.64	0.96	0.00	0.32	1.61	0.00	2.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	107.02	0.71	2.14	0.71	0.71	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	114.07	0.58	2.34	2.34	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	131.57	3.01	2.71	0.60	1.20	0.60	0.30	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	122.36	0.00	1.19	2.38	1.19	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	149.52	1.02	2.03	0.51	0.51	1.53	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	150.27	1.27	2.04	0.51	1.53	2.04	0.76	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	94.03	1.91	0.64	0.64	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	150.17	2.16	3.45	0.86	0.43	0.43	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	138.65	1.69	2.33	0.42	0.21	0.42	0.42	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	119.76	1.45	0.58	1.16	1.45	0.58	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	140.77	3.78	2.83	0.00	0.94	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	149.69	2.03	2.37	0.51	1.86	0.68	0.00	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	97.29	2.32	0.00	2.32	0.00	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	177.46	6.34	2.11	0.00	2.11	2.11	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	160.38	4.07	3.86	0.86	1.93	1.29	0.00	2.36
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	144.40	1.80	0.60	0.00	0.60	1.80	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	148.71	0.00	2.19	0.73	2.92	0.00	0.00	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	140.00	3.22	2.76	0.92	0.69	0.46	0.23	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	112.21	0.00	0.00	7.65	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	137.54	2.03	3.31	1.02	1.27	1.02	0.51	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	126.13	3.72	5.78	0.83	1.24	0.62	1.03	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	97.31	2.14	1.84	1.84	0.61	0.61	0.61	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	115.68	2.39	4.30	3.35	3.35	0.96	0.48	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	108.43	1.77	4.66	0.89	2.44	0.44	0.44	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	53.40	1.53	0.00	4.58	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	103.02	1.66	3.32	1.11	1.66	1.11	0.00	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	105.12	2.12	3.44	1.59	2.38	0.53	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	86.86	2.91	1.45	2.18	1.09	1.09	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	104.03	0.74	5.16	0.12	0.12	0.49	0.00	0.98
Astrocyte - cerebellum, donor2	11580-120F5	52.89	0.34	1.54	0.17	0.00	0.00	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	48.03	0.42	0.42	0.42	0.00	0.21	0.00	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	267.02	0.00	3.49	3.49	2.44	0.70	0.70	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	188.63	0.81	2.10	2.26	2.26	1.62	1.29	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	187.35	0.30	2.24	1.49	2.98	1.94	0.89	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	391.08	2.64	5.50	3.21	0.57	1.61	0.69	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	403.78	2.13	4.13	2.26	1.75	2.00	1.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	362.33	2.96	3.87	1.48	1.48	2.16	1.14	0.23
Basophils, donor1	12241-129G9	1681.39	104.09	3.66	4.97	6.28	2.35	3.66	1.57
Basophils, donor2	12242-129H1	1825.98	148.65	5.41	10.10	8.30	3.61	3.97	1.80
Basophils, donor3	12243-129H2	1007.52	67.47	5.59	3.97	2.94	2.65	2.35	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	45.28	0.65	0.00	0.00	0.00	0.43	0.00	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	18.74	0.00	0.46	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	86.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	63.39	1.26	1.88	0.00	0.00	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	52.61	0.42	1.25	0.21	0.42	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	61.03	0.92	1.38	0.23	0.23	0.23	0.00	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	155.29	0.36	0.36	0.72	0.90	1.08	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	482.09	6.60	2.27	2.58	2.47	1.96	0.82	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	504.70	4.19	5.59	6.06	5.59	3.03	3.96	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	1067.73	17.91	3.20	6.40	2.56	1.92	1.60	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	1044.54	10.34	0.00	20.68	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	1111.90	117.78	4.51	12.96	14.65	4.51	5.07	2.82
CD14+ Monocytes, donor2	11305-117B9	876.41	79.81	19.86	15.40	9.28	7.42	11.88	1.30
CD14+ Monocytes, donor3	11381-118B4	974.96	79.69	6.15	16.25	14.05	8.56	18.00	2.85
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	340.22	0.85	3.96	2.83	3.40	1.98	0.85	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	406.75	1.14	4.55	2.27	1.52	0.38	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	386.60	0.66	1.97	1.64	2.96	2.63	0.33	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	379.44	6.79	4.34	4.48	2.17	2.75	2.31	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	357.57	6.03	3.32	3.62	2.72	3.92	1.51	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	508.61	12.79	6.16	5.21	3.55	3.32	3.08	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	472.73	9.54	8.70	7.53	4.85	4.69	6.36	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	493.23	11.32	8.83	4.97	4.97	1.38	3.59	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	657.01	21.82	7.44	5.95	4.96	5.21	1.74	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	533.56	13.31	7.64	7.05	2.74	5.09	3.72	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	585.60	14.78	5.34	4.81	3.56	5.16	3.20	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	934.07	35.04	4.13	3.92	2.39	1.31	1.96	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	647.83	25.29	10.30	9.83	7.73	3.28	5.15	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	868.08	27.46	21.65	11.62	10.03	5.81	5.28	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	858.64	33.28	14.42	3.33	4.44	4.44	5.55	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	419.62	11.16	6.69	5.80	2.68	5.21	1.78	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	437.21	9.78	8.58	3.79	2.20	3.59	2.39	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	748.89	17.49	4.58	3.96	4.16	2.29	2.71	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	600.10	19.90	7.78	6.63	5.26	4.80	2.75	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	673.41	31.89	2.04	2.49	4.52	2.49	1.13	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	701.39	28.37	10.91	8.73	6.98	5.24	5.24	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	416.13	9.41	7.80	5.11	2.96	2.42	3.77	1.88
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	527.92	14.31	4.88	5.93	4.36	3.49	2.09	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	621.55	15.57	10.94	6.31	5.05	1.26	4.21	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	531.48	15.80	9.55	7.72	6.06	4.41	2.57	2.02
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	655.57	13.74	6.34	6.34	4.23	4.23	8.10	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	900.70	21.06	8.77	7.02	5.26	5.26	4.39	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	506.73	10.81	9.42	8.54	8.02	6.28	5.23	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	611.04	22.67	16.35	5.20	9.29	7.81	3.72	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	964.37	34.49	5.17	5.60	2.59	3.23	2.37	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	448.80	10.24	10.24	6.14	4.09	4.09	2.05	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	718.81	25.96	3.48	3.01	3.48	0.93	1.16	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	944.44	28.30	4.64	4.87	3.71	2.55	1.39	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	795.13	41.20	2.83	3.71	2.62	0.87	0.87	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	823.73	44.58	5.08	3.00	3.46	1.85	0.92	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	738.23	24.04	2.60	3.47	2.17	0.43	0.65	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	846.66	32.55	3.11	4.05	3.27	0.93	1.40	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	785.03	26.02	5.24	4.19	3.14	1.22	0.52	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	1091.66	29.21	2.01	2.68	1.56	2.90	2.68	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	891.84	37.00	5.10	5.61	4.59	1.28	0.77	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	813.27	36.23	5.49	4.39	3.73	1.54	1.32	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	898.19	24.84	3.37	4.84	5.47	1.68	1.68	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	1071.03	0.00	4.06	6.10	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	1056.29	2.03	2.03	1.36	2.03	0.68	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1235.47	6.21	0.00	0.00	2.07	2.07	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1063.94	10.13	14.93	12.26	10.13	3.73	3.73	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1604.99	2.68	0.00	2.68	3.22	3.22	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	1225.58	4.91	2.11	3.51	2.11	2.81	0.70	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1096.53	7.84	3.92	3.92	2.35	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1363.11	6.59	0.00	0.00	0.00	2.64	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	1473.67	50.14	27.94	26.30	25.48	13.97	21.37	0.82
CD19+ B Cells, donor2	11624-122B4	1305.77	32.64	21.76	13.06	12.33	5.80	11.61	1.45
CD19+ B Cells, donor3	11705-123B4	1306.99	45.94	14.14	16.66	14.14	7.57	8.58	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	883.27	4.04	3.64	4.44	4.44	2.83	0.40	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	598.84	3.20	3.20	7.59	5.99	1.60	2.00	1.20
CD34+ Progenitors, donor1	11545-120B6	715.89	17.07	0.00	1.00	3.01	0.00	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	1337.10	67.98	20.79	1.69	3.37	0.56	0.00	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	809.00	7.14	4.88	3.01	2.25	0.75	0.38	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	897.42	9.24	2.71	2.93	2.03	0.00	2.03	1.58
CD4+ T Cells, donor1	11225-116C1	1995.23	179.24	22.85	18.57	15.71	10.00	10.35	2.86
CD4+ T Cells, donor2	11306-117C1	1228.40	105.94	47.15	25.11	26.94	11.63	15.92	3.67
CD4+ T Cells, donor3	11382-118B5	1392.90	108.88	15.86	21.96	27.14	11.89	12.50	3.96
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	792.76	4.34	1.28	1.79	0.51	1.02	0.00	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	822.70	3.14	3.37	1.57	2.02	3.14	1.12	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	785.34	3.45	3.45	1.72	2.30	1.72	0.86	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2311.19	73.48	1.90	8.06	4.74	4.27	1.90	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2585.95	68.13	12.64	11.24	10.53	1.40	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	2076.62	82.41	16.48	6.59	16.48	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	683.56	7.51	1.73	1.73	2.17	1.59	0.58	5.35
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	488.22	3.56	5.76	4.91	3.39	1.53	0.68	2.37
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	475.40	4.03	5.96	5.48	4.03	1.45	1.77	2.90
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1684.71	53.35	17.04	7.17	10.31	3.14	2.69	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1476.51	39.83	10.48	5.59	3.14	5.24	1.05	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1719.45	65.12	8.36	5.28	7.48	3.08	2.20	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	824.31	5.48	1.69	1.26	1.69	2.11	0.84	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	527.94	3.53	4.57	5.82	3.12	2.91	1.87	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	485.82	4.01	6.35	4.01	3.34	1.67	2.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2128.70	49.49	13.87	6.53	6.53	5.98	2.72	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	2597.75	54.13	10.18	10.72	6.43	6.97	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	2128.56	43.04	17.93	14.35	5.38	7.17	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	679.41	4.45	3.71	1.30	2.60	1.85	0.93	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	562.34	4.12	4.98	2.60	1.30	1.52	0.87	1.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	540.72	6.09	2.52	1.89	0.42	0.63	0.42	3.15
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1646.75	43.48	8.60	5.56	3.03	1.52	1.01	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1768.10	59.36	6.07	6.07	5.20	3.03	1.30	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	2176.46	85.86	3.92	12.20	6.97	6.97	3.49	4.79
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1710.27	6.93	3.96	3.46	2.97	1.48	0.49	2.97
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1438.32	3.69	1.85	2.77	4.62	1.85	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1493.53	4.19	1.40	5.58	4.19	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1724.99	6.09	38.49	1.66	2.22	1.38	0.55	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	2152.81	7.36	21.59	0.49	0.74	0.98	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1643.19	6.16	6.16	0.00	4.62	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1481.53	7.88	2.51	3.58	2.51	4.66	2.15	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1638.44	9.69	0.00	2.77	2.77	2.77	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	1875.65	231.47	15.39	12.77	22.26	9.49	5.57	1.64
CD8+ T Cells, donor2	11307-117C2	1228.04	110.38	43.17	23.28	16.52	10.14	18.02	3.00
CD8+ T Cells, donor3	11383-118B6	1543.21	124.73	12.37	35.10	27.02	17.93	19.69	3.28
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	198.19	3.44	1.61	2.29	2.29	0.46	1.15	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	184.76	3.12	1.20	3.35	1.44	1.20	1.20	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	191.24	4.38	0.27	1.37	1.09	0.27	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	249.48	5.40	1.50	3.00	1.80	0.60	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	191.51	3.36	1.68	1.92	1.68	0.72	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	187.37	3.87	1.14	2.05	2.50	0.23	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	127.33	1.52	2.39	1.52	3.04	0.43	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	121.07	3.42	2.63	2.63	1.32	1.05	1.32	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	120.07	3.05	1.88	3.28	1.17	0.23	1.17	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	168.45	2.72	0.30	1.81	2.72	1.51	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	151.35	4.94	2.32	2.61	1.45	0.00	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	165.72	3.20	2.40	0.80	1.07	0.53	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	119.07	4.38	2.19	1.75	3.06	1.75	3.06	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	128.89	6.83	2.28	2.28	0.91	0.00	3.64	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	87.27	4.48	2.98	1.49	2.98	0.75	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	216.81	4.32	1.80	0.36	0.72	0.00	0.00	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	244.56	2.88	1.44	1.73	2.01	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	171.35	3.54	0.71	1.65	1.89	0.71	0.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	152.75	1.58	0.95	2.85	2.22	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	163.93	3.69	2.46	1.85	3.08	0.62	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	135.93	3.21	0.32	0.96	2.24	0.64	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	171.34	4.21	2.29	1.91	4.97	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	171.04	3.55	1.97	2.36	4.34	1.97	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	160.36	3.03	1.51	1.51	2.27	2.27	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	301.91	9.64	2.41	7.23	8.83	0.80	4.01	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	304.95	7.69	0.70	4.20	4.90	1.40	2.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	309.54	8.01	4.01	6.01	5.01	4.01	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	180.95	0.00	3.66	1.83	5.48	7.31	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	84.98	1.48	0.00	1.48	0.00	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	90.29	0.74	0.00	0.21	0.11	0.00	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	155.31	1.04	5.20	0.69	1.39	0.69	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	95.95	1.42	0.00	0.36	0.00	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	162.70	1.02	1.25	2.16	1.71	0.91	0.34	0.68
Chondrocyte - re diff, donor2	11339-117F7	252.46	0.90	1.79	0.00	0.00	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	240.22	1.21	0.40	2.43	2.43	2.02	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	284.49	1.72	2.41	1.61	1.49	0.57	0.57	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	174.65	1.50	3.85	0.86	1.71	1.07	0.64	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	191.16	2.04	0.53	1.50	1.42	1.50	0.71	1.50
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	395.87	3.03	0.73	1.19	0.64	0.83	0.55	3.48
Corneal Epithelial Cells, donor1	11526-119I5	32.94	0.22	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	65.98	0.00	0.00	0.00	0.00	1.14	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	62.12	0.26	0.51	0.26	0.26	0.26	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	215.94	1.98	3.14	1.82	1.65	0.83	1.16	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	221.10	0.95	1.58	1.58	0.32	0.63	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	186.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	161.23	1.30	1.40	2.05	2.05	1.62	1.51	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1149.62	41.34	7.52	5.12	5.12	1.02	1.02	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1186.27	37.87	1.96	1.96	0.65	1.96	0.00	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	1251.96	38.23	9.19	0.00	0.48	1.45	0.97	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	88.39	0.50	0.17	0.83	0.67	0.17	0.50	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	64.55	1.17	0.59	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	98.98	1.13	1.13	0.57	0.57	0.00	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	68.02	1.57	0.00	0.00	0.79	0.00	0.39	1.57
Endothelial Cells - Artery, donor1	11264-116G4	65.74	0.87	1.16	0.00	0.29	0.29	0.00	1.45
Endothelial Cells - Artery, donor2	11341-117F9	120.93	2.12	1.18	1.18	0.47	0.24	0.47	1.88
Endothelial Cells - Artery, donor3	11413-118E9	78.01	0.70	0.35	0.00	0.35	0.18	0.18	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	176.88	2.44	2.44	1.77	1.55	1.77	0.22	3.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	187.43	1.22	0.61	1.52	1.52	0.91	0.61	3.96
Endothelial Cells - Lymphatic, donor3	11393-118C7	212.56	3.38	1.41	1.13	0.85	1.41	0.00	4.51
Endothelial Cells - Microvascular, donor1	11265-116G5	70.42	0.89	2.38	0.30	0.59	0.59	0.00	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	66.12	1.56	0.00	0.00	0.00	0.00	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	62.39	0.85	0.71	0.57	0.71	0.57	0.14	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	215.26	2.00	6.40	0.00	0.40	0.40	0.00	3.20
Endothelial Cells - Thoracic, donor2	11343-117G2	67.61	1.57	1.57	0.00	0.00	0.00	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	351.00	1.24	1.49	1.37	0.62	0.87	0.37	3.23
Endothelial Cells - Umbilical vein, donor2	11324-117E1	267.01	1.52	3.69	1.52	1.74	0.00	7.39	3.04
Endothelial Cells - Umbilical vein, donor3	11400-118D5	217.63	1.22	0.98	0.73	0.49	1.10	3.54	3.05
Endothelial Cells - Vein, donor1	11267-116G7	71.66	0.00	0.00	0.00	0.00	0.00	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	58.67	0.00	0.00	0.00	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	103.31	0.94	0.63	0.63	0.79	0.47	0.63	1.10
Eosinophils, donor1	12244-129H3	899.57	30.49	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3899.57	110.57	3.30	9.90	4.95	6.60	6.60	6.60
Eosinophils, donor3	12246-129H5	3038.93	139.11	14.27	10.70	14.27	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	30.54	0.00	0.73	0.00	0.00	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	170.77	3.28	2.87	1.23	1.64	1.64	2.46	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.79	0.77	0.00	0.00	0.00	0.77	0.00	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	46.91	0.33	0.11	0.00	0.00	0.22	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	148.08	2.18	0.49	0.36	0.36	0.61	0.00	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	542.88	21.15	10.24	4.91	3.55	2.87	1.36	3.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	129.94	1.27	1.79	2.21	1.05	1.48	0.42	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	276.93	5.27	28.46	0.79	1.84	2.11	0.79	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	146.50	1.66	0.33	1.00	0.66	1.33	1.00	1.33
Fibroblast - Cardiac, donor1	11268-116G8	83.47	1.36	1.81	0.45	0.00	0.45	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	59.12	0.76	0.76	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	70.34	0.79	0.32	0.63	0.00	0.32	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	287.65	0.61	2.12	0.30	0.00	1.82	0.30	1.52
Fibroblast - Cardiac, donor5	11456-119A7	162.94	0.89	6.22	0.89	1.14	0.38	0.25	0.89
Fibroblast - Cardiac, donor6	11460-119B2	141.89	1.67	5.15	0.30	1.36	0.15	0.45	1.36
Fibroblast - Choroid Plexus, donor1	11492-119E7	118.72	0.94	6.43	0.40	0.27	0.27	0.00	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	107.43	1.73	0.00	0.43	0.43	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	121.58	0.00	1.46	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	56.51	0.23	0.23	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	177.07	1.19	0.68	0.68	0.17	1.36	0.00	0.85
Fibroblast - Dermal, donor1	11269-116G9	110.58	1.41	2.35	0.70	0.47	0.00	0.94	2.35
Fibroblast - Dermal, donor2	11346-117G5	80.19	0.94	0.00	0.00	0.00	0.00	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	133.34	0.73	0.73	0.85	1.09	0.60	0.12	0.73
Fibroblast - Dermal, donor4	11450-119A1	144.25	0.68	3.28	0.57	0.23	0.45	0.34	0.45
Fibroblast - Dermal, donor5	11454-119A5	138.52	0.52	4.71	0.35	0.35	0.52	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	155.60	0.65	3.74	0.32	0.81	0.32	0.32	1.30
Fibroblast - Gingival, donor1	11237-116D4	213.02	0.83	1.25	1.25	1.46	0.62	0.42	2.29
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	182.09	0.79	3.67	1.83	0.52	0.52	1.83	1.05
Fibroblast - Gingival, donor2	11318-117D4	154.45	0.53	2.64	2.24	1.32	0.92	0.53	1.05
Fibroblast - Gingival, donor3	11394-118C8	199.37	0.77	0.29	0.97	0.68	0.77	0.68	1.26
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	179.73	0.00	1.04	1.04	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	85.28	0.35	1.94	2.29	0.53	0.35	2.29	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	189.41	0.62	2.34	0.47	0.16	0.78	0.31	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	144.42	0.68	1.49	0.81	1.35	0.81	0.68	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	43.76	0.00	1.41	0.00	0.00	0.35	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	162.33	0.73	1.75	1.17	0.73	0.58	0.88	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	207.26	0.68	1.91	0.41	0.82	0.95	1.23	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	181.21	0.88	1.54	0.55	0.33	0.55	0.33	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	236.69	0.15	3.52	1.61	2.05	0.29	1.76	1.17
Fibroblast - Lung, donor1	11270-116H1	58.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	171.60	0.00	1.49	0.00	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	111.43	0.63	0.42	0.63	0.42	0.21	0.00	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	50.81	0.00	1.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	43.36	0.00	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	17.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	104.74	0.00	0.41	0.00	0.00	0.00	0.00	1.22
Fibroblast - Mammary, donor2	11620-122A9	55.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	53.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	179.81	0.39	1.16	1.94	1.75	0.78	0.19	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	163.06	1.06	1.67	0.61	0.46	0.91	0.30	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	235.92	1.53	0.31	0.31	0.00	0.31	0.31	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	165.62	0.38	1.14	0.76	0.00	0.38	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	132.30	0.54	1.08	1.08	0.54	0.81	1.35	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	103.80	0.23	0.23	1.39	0.81	0.70	2.20	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	141.81	2.54	0.44	0.44	0.22	0.22	0.00	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	82.29	0.61	0.81	0.00	0.20	0.81	0.00	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	52.12	0.00	1.34	0.00	0.67	0.67	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	109.12	1.19	0.00	0.00	0.40	0.40	0.40	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	315.13	3.18	14.09	0.79	0.40	1.98	0.40	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	220.78	1.24	3.20	1.24	0.53	0.89	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	201.62	0.39	2.37	1.58	0.99	0.99	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	286.11	2.11	17.45	0.30	0.60	1.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	283.26	1.40	11.55	0.22	0.43	0.22	0.11	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	346.71	5.31	21.26	0.25	1.01	1.52	0.25	1.77
Fibroblast - skin normal, donor1	11553-120C5	167.52	1.15	3.28	1.15	0.82	0.33	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	375.75	5.41	3.21	3.61	2.61	4.61	1.00	1.80
Fibroblast - skin normal, donor2	11561-120D4	171.09	1.51	8.14	0.10	0.60	0.10	0.10	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	334.88	6.65	16.32	1.51	1.81	0.91	0.00	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	254.34	0.66	3.15	1.24	1.41	1.24	0.75	0.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	320.19	0.68	30.43	0.68	0.85	0.17	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	337.96	12.81	15.11	0.66	0.66	1.31	0.00	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	182.79	0.96	9.16	0.00	0.11	0.21	0.21	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	128.87	0.51	0.84	0.34	0.34	0.17	0.34	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	107.42	0.63	0.00	0.00	0.00	0.31	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	3456.93	22.16	0.00	0.00	0.00	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	509.85	1.74	3.49	6.97	2.61	0.87	3.49	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	155.85	3.12	1.21	0.35	1.04	0.69	0.17	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	189.72	3.90	1.04	1.04	1.04	1.04	1.30	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	180.14	2.04	0.77	1.02	1.02	0.00	1.02	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	269.47	4.59	1.53	1.53	1.53	0.77	4.59	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	307.55	3.19	1.91	3.83	2.55	1.28	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	534.87	5.42	0.29	5.71	2.00	1.43	1.14	4.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	674.23	0.83	7.17	10.75	12.96	7.45	4.14	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	482.45	1.83	3.65	11.64	10.73	4.57	3.42	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	391.51	2.77	1.98	4.56	5.55	3.76	2.58	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	582.07	1.06	5.02	10.31	11.10	3.70	5.29	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	613.81	1.96	4.57	11.09	6.85	2.94	3.59	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	433.82	6.19	2.21	4.86	6.19	2.21	3.10	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	317.27	0.57	2.54	3.25	2.69	1.84	0.71	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	278.06	0.86	1.60	1.48	1.48	1.72	0.37	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	229.67	1.61	1.88	2.15	1.61	1.61	1.34	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	267.24	0.87	0.37	1.24	0.50	0.87	0.50	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	283.36	1.11	0.69	1.11	1.11	1.25	0.14	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	206.96	1.63	2.85	1.42	0.81	1.02	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	208.56	0.91	3.42	4.11	1.83	1.14	2.74	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	227.83	1.00	1.87	1.74	1.99	0.25	0.25	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	168.74	0.66	1.53	1.75	0.87	0.87	1.31	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	222.79	1.77	3.25	2.95	0.89	1.18	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	288.03	1.11	2.86	0.79	2.86	2.07	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	183.43	1.34	2.01	1.12	0.89	0.67	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	238.13	0.81	5.44	2.42	2.82	3.02	1.61	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	298.57	0.17	2.21	1.70	2.04	1.19	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	242.52	1.51	1.24	0.89	1.06	0.80	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	248.90	1.04	2.39	0.52	0.10	0.31	0.31	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	282.29	0.34	0.85	0.34	0.34	0.51	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	279.62	0.89	1.33	0.66	1.66	1.33	0.11	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	285.20	2.33	2.16	1.08	1.33	0.67	0.17	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	309.13	1.43	1.84	0.82	1.43	1.23	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	247.15	0.83	3.92	2.89	1.65	2.06	2.06	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	277.74	1.38	1.61	2.42	2.54	2.19	0.58	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	264.99	2.17	5.00	2.84	2.50	2.33	1.50	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	179.87	0.22	3.09	1.98	1.32	0.66	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	302.93	1.97	2.09	2.21	2.09	1.97	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	247.84	0.97	3.08	1.46	2.59	0.81	0.97	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	239.89	1.60	1.28	3.53	4.81	2.57	1.28	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	194.91	0.85	1.33	1.42	1.14	1.04	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	171.62	0.95	2.06	2.53	1.27	0.79	1.27	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	255.43	2.13	1.52	0.91	0.00	0.30	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	202.28	0.94	2.30	2.30	1.67	1.36	0.52	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	205.06	1.54	1.10	2.63	1.32	1.32	1.98	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	176.18	0.84	2.52	3.65	3.09	1.96	1.40	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	182.58	1.11	1.02	0.74	0.65	1.48	0.46	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	153.22	1.60	1.60	1.07	0.80	0.80	0.80	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	134.03	1.22	0.77	0.61	0.92	0.46	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	162.83	0.91	0.39	0.78	1.42	1.30	0.39	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	227.70	1.90	2.17	2.71	0.54	1.08	1.08	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	184.35	1.66	2.95	1.84	1.11	2.21	0.55	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	150.01	0.88	1.54	2.19	1.97	1.32	0.88	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	326.28	2.98	0.99	0.99	0.99	0.00	1.98	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	141.28	0.40	2.37	2.11	1.19	0.79	0.26	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	130.34	1.01	1.82	1.82	2.22	1.61	0.20	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	153.77	0.51	0.00	0.25	0.00	0.51	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	385.58	2.79	8.36	0.60	0.60	1.19	0.20	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	354.84	1.69	1.08	0.15	0.62	2.00	0.31	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	554.62	2.05	1.23	0.20	0.41	1.64	0.61	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	283.20	1.56	2.19	0.00	0.94	0.31	0.00	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	218.42	1.98	0.85	0.57	0.00	0.57	0.00	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	319.62	4.15	17.99	2.31	5.07	1.38	2.77	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	373.69	2.47	4.95	2.47	4.95	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	284.30	3.48	6.96	1.55	2.71	0.77	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	364.21	1.60	1.60	3.21	3.21	4.81	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	333.86	1.74	3.48	0.00	3.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	287.07	1.63	1.95	3.58	1.95	1.30	1.63	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	337.68	2.06	4.53	4.94	3.29	1.24	0.00	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	446.52	0.00	0.00	6.66	16.66	6.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	295.87	1.12	6.43	4.75	2.52	1.40	1.68	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	275.86	1.63	2.29	2.94	2.29	1.31	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	390.06	2.52	5.03	7.55	3.36	7.55	3.36	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	319.66	1.91	5.73	5.41	4.45	1.27	2.23	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	289.39	2.38	1.70	1.36	1.02	1.02	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	451.04	4.18	0.00	8.35	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	291.50	1.72	6.30	1.72	0.57	1.15	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	171.08	1.18	1.48	1.18	2.37	0.59	1.48	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	381.18	1.69	1.69	3.39	8.47	5.08	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	356.22	2.07	4.97	4.56	2.07	1.66	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	398.58	2.07	4.14	0.69	2.53	1.84	0.92	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	442.55	0.00	5.27	0.00	15.81	5.27	15.81	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	341.74	1.54	5.38	2.31	3.46	1.54	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	269.90	0.65	3.59	2.28	3.59	1.30	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	353.82	2.01	2.01	2.68	2.68	2.01	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	403.38	1.54	6.16	1.93	2.70	2.31	2.31	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	610.39	6.50	4.79	5.48	5.82	2.74	1.03	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	427.38	2.48	4.97	9.94	17.39	27.33	12.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	364.74	0.00	8.02	5.19	5.19	2.36	3.30	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	298.73	1.21	4.83	2.41	3.02	1.21	4.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	486.29	1.53	3.05	4.58	3.56	3.56	4.07	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	408.01	0.80	6.78	2.39	3.99	1.20	1.99	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	480.53	0.99	11.84	6.41	5.92	3.45	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	669.31	3.54	15.35	18.89	9.44	5.90	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	316.81	0.58	11.09	5.25	5.25	1.17	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	454.68	0.44	9.22	2.19	4.39	1.76	3.51	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	495.90	2.54	4.24	7.63	3.39	4.24	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	371.88	1.19	11.94	5.97	6.57	1.79	2.39	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	323.17	4.37	3.88	0.97	1.94	1.94	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	97.01	2.28	2.28	0.00	0.00	0.00	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	92.31	1.25	2.49	0.42	0.42	0.42	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	48.35	1.12	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	209.96	9.20	1.59	1.90	3.81	1.27	0.63	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	85.22	4.18	0.42	0.84	0.84	1.25	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	146.79	2.55	1.86	1.04	0.35	0.81	0.23	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	159.35	2.53	1.69	0.34	0.84	0.68	0.84	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	167.21	2.73	0.68	1.14	0.23	0.68	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	150.85	2.08	1.20	1.09	0.98	0.98	0.66	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	158.82	4.51	0.86	0.21	1.07	0.21	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	158.88	2.80	1.51	0.65	0.65	0.65	0.22	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	134.13	1.62	1.00	0.75	0.50	0.50	0.37	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	134.32	1.20	1.54	0.51	0.34	0.00	0.34	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	136.48	1.28	1.60	0.64	0.32	0.64	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	52.04	0.00	0.00	0.00	0.00	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	32.89	0.43	0.00	0.00	0.00	0.00	0.43	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	0.00	2.64	2.64	0.00	2.64	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	56.44	0.35	0.35	0.00	0.35	0.00	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	29.79	0.00	0.00	0.73	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	92.31	1.22	0.52	0.17	0.00	0.17	0.00	0.17
Hepatocyte, donor1	11523-119I2	418.87	3.63	12.11	3.63	3.63	2.42	3.63	1.21
Hepatocyte, donor2	11603-120I1	441.71	6.46	2.15	7.54	7.54	2.15	5.39	2.15
Hepatocyte, donor3	11684-122I1	377.94	1.84	4.91	10.43	4.91	4.91	3.07	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	571.75	13.05	14.36	8.48	10.44	3.26	5.87	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	405.67	2.45	1.92	2.80	2.80	2.80	0.70	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	120.74	0.55	0.69	0.82	0.14	0.27	0.00	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	63.68	0.00	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	100.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	70.60	1.38	0.00	0.00	1.38	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	52.56	5.01	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	76.89	2.56	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	86.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	90.96	0.00	1.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	65.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	71.47	0.00	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	59.87	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	73.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	71.80	1.26	0.00	0.00	0.00	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	60.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	71.71	1.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	80.50	0.00	3.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	94.53	0.81	0.00	0.00	0.00	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	61.29	1.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	139.04	1.61	0.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	108.95	0.00	0.92	0.00	0.00	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	108.57	1.42	0.94	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	80.72	1.81	0.00	0.91	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	156.04	1.08	1.08	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	133.40	2.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	197.16	16.43	0.00	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	116.06	1.91	0.00	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	118.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	142.24	0.00	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	115.68	0.71	0.71	0.00	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	96.23	0.00	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	166.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	90.44	0.31	0.62	0.00	0.00	0.62	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	64.97	1.76	3.51	0.00	0.00	1.76	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	81.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	63.98	0.00	0.00	0.00	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	61.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	87.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	47.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	47.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	52.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	43.74	0.00	0.00	0.00	0.00	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	56.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	56.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	57.07	1.84	1.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	93.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	33.84	0.00	0.00	0.00	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	149.41	2.12	0.24	0.16	0.24	0.49	0.08	0.90
Keratinocyte - epidermal, donor2	11349-117G8	44.51	1.17	0.59	0.00	0.00	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	190.07	1.14	1.04	0.85	1.14	1.33	0.47	1.23
Keratinocyte - oral, donor1	11251-116E9	217.84	1.25	0.45	0.57	0.68	0.68	0.34	0.57
Keratocytes, donor1	11527-119I6	48.48	0.00	0.00	0.00	0.34	0.69	0.00	0.69
Keratocytes, donor2	11607-120I5	58.59	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	147.61	0.99	0.40	0.00	0.40	0.40	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	259.35	0.00	2.20	0.00	2.20	0.00	4.40	2.20
Lens Epithelial Cells, donor1	11529-119I8	116.50	1.08	1.08	4.31	1.08	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	130.56	0.23	1.27	0.46	0.69	1.15	0.00	0.81
Lens Epithelial Cells, donor3	11690-122I7	104.74	1.21	0.00	0.10	0.00	0.30	0.00	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	101.86	0.95	0.24	0.00	0.24	0.12	0.00	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	66.70	0.84	1.67	0.56	0.56	0.28	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	139.15	1.73	1.26	0.79	0.63	0.31	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	84.96	1.08	0.54	0.00	1.08	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	58.31	0.00	0.95	0.00	0.32	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	76.66	0.65	0.75	0.22	0.11	0.65	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	104.24	0.82	2.05	0.41	0.41	0.82	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	48.79	0.76	0.25	0.00	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	91.77	0.84	0.28	0.28	0.14	0.99	0.14	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	89.79	1.19	1.58	1.19	0.40	0.00	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	88.41	0.97	1.16	0.39	1.16	0.58	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	57.03	0.00	0.19	0.19	0.19	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	94.77	0.00	2.79	1.39	0.70	0.35	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	77.76	1.19	0.48	0.48	0.00	0.48	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	83.37	0.69	0.41	0.27	0.27	0.55	0.14	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	82.84	1.23	1.85	0.00	0.62	1.23	0.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	47.07	0.94	0.62	0.00	0.31	0.31	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	95.34	0.37	0.55	0.00	0.18	0.18	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	94.78	2.30	0.33	0.33	0.66	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	49.79	0.59	0.88	0.29	0.00	0.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	71.69	0.50	0.25	0.25	0.25	0.50	0.00	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	95.05	2.42	2.91	0.97	2.42	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	77.83	1.62	0.27	0.00	0.81	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	102.18	1.36	1.06	0.45	0.45	0.45	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	72.06	0.52	1.56	0.00	1.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	84.18	1.88	1.47	1.26	0.63	0.84	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	110.22	1.05	0.45	0.45	0.30	0.15	0.15	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	79.11	1.38	0.69	0.00	0.00	0.00	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	73.94	1.51	0.56	0.00	0.19	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	42.31	0.53	0.53	0.11	0.32	0.00	0.11	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	84.80	0.97	1.94	0.48	1.45	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	63.84	0.33	0.33	0.33	0.33	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	41.50	0.99	0.62	0.00	0.25	0.50	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	114.39	1.11	1.48	0.74	0.74	0.74	0.37	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	68.19	0.74	0.74	0.25	0.00	0.25	0.25	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	43.59	0.27	0.27	0.00	0.14	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	74.94	0.96	1.29	0.00	1.29	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	106.21	2.13	1.22	1.22	0.61	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	83.28	1.26	1.96	0.70	0.84	0.28	0.28	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	78.22	1.07	1.07	0.36	0.36	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	43.15	0.97	0.48	0.48	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	29.10	0.00	0.62	0.16	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	75.56	1.07	0.36	0.00	0.36	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	68.60	0.65	0.33	0.33	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	25.43	0.24	0.47	0.00	0.00	0.24	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	77.84	0.50	0.12	0.00	0.00	0.25	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	40.21	0.00	0.00	0.00	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	61.76	1.19	0.60	0.60	0.60	0.60	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	192.61	6.80	0.00	0.00	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	190.25	3.84	1.53	0.77	0.77	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	165.52	0.00	1.48	0.74	0.00	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	242.88	2.96	3.39	2.54	2.12	1.69	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	217.33	4.22	2.11	2.81	2.81	2.11	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	244.70	3.74	0.00	0.00	0.00	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	204.05	3.61	3.61	0.00	1.03	1.55	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	196.26	2.38	1.19	2.38	0.00	3.57	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	220.54	2.49	1.13	0.23	0.00	0.00	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	220.74	3.78	4.94	3.20	2.91	2.91	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	245.35	2.25	8.10	2.70	2.70	4.50	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	231.14	3.52	0.27	0.41	0.54	0.14	0.14	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	244.44	4.62	1.03	2.05	1.54	2.05	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	276.64	2.82	1.76	1.06	0.35	0.71	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	262.52	1.33	0.67	0.00	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	276.09	1.53	3.57	1.02	1.53	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	286.82	4.80	5.87	2.67	2.13	2.93	0.27	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	313.65	3.21	3.59	2.27	2.46	1.70	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	260.15	5.52	1.84	3.07	1.23	1.23	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	315.57	8.97	4.08	1.63	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	253.02	2.08	5.21	1.67	2.29	1.87	0.21	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	228.41	4.48	3.08	2.24	2.52	1.40	0.28	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	232.86	4.12	4.12	1.03	2.06	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	221.79	1.45	6.10	2.32	2.90	2.61	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	198.19	1.79	5.68	2.39	2.99	0.60	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	214.66	3.32	3.87	1.66	0.55	1.11	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	232.24	4.60	2.47	0.71	0.35	2.47	0.71	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	192.87	4.79	1.84	1.11	1.11	1.84	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	189.96	0.00	3.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	201.47	0.77	2.69	0.77	1.54	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	156.82	2.26	2.26	1.13	1.13	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	156.71	2.46	4.10	0.82	0.00	0.82	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	173.52	1.81	0.90	3.16	0.00	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	117.78	1.44	2.87	1.44	1.44	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	159.09	2.24	2.24	1.49	0.00	0.00	0.75	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	140.83	1.11	1.49	0.74	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	91.75	0.86	1.29	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	114.74	0.86	2.57	0.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	104.95	1.00	2.67	0.33	0.00	2.33	0.67	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	115.84	2.41	4.22	1.21	2.41	1.21	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	121.58	0.71	2.13	0.00	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	129.58	2.41	1.03	1.37	1.37	1.37	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	93.93	2.15	1.07	0.00	1.61	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	104.37	0.00	0.67	1.35	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	127.42	1.11	2.96	2.22	0.74	2.22	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	109.32	2.33	0.00	0.00	0.00	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	92.02	0.00	4.23	1.06	0.00	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	139.25	1.20	4.00	0.40	0.00	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	293.66	6.54	3.63	2.18	2.18	0.73	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	317.34	5.37	4.60	2.30	0.00	3.07	1.53	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	304.35	7.40	4.44	0.49	1.48	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	248.41	7.53	2.82	2.82	0.94	3.76	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	284.09	3.52	3.52	0.50	2.01	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	273.98	3.15	4.51	1.80	0.90	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	244.40	8.61	5.16	1.72	1.72	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	266.32	4.45	4.01	0.45	0.89	1.78	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	272.94	2.74	1.96	1.56	0.39	0.39	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	258.62	4.62	5.28	1.32	1.98	1.32	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	321.73	2.08	1.56	1.04	2.08	3.11	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	345.24	4.81	1.31	1.75	0.44	3.50	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	271.72	4.47	6.71	0.56	1.68	1.12	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	291.48	4.86	0.44	0.88	1.77	1.32	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	305.10	5.79	3.47	1.16	2.70	1.93	0.39	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	276.47	4.56	2.03	2.53	1.01	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	280.20	5.29	2.40	0.96	0.96	1.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	248.07	5.17	3.98	1.19	1.19	2.78	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	226.64	3.65	2.43	0.61	1.22	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	213.04	3.46	3.46	0.69	0.00	1.38	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	252.31	3.80	2.28	0.76	0.38	1.52	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	238.07	1.55	2.58	1.55	1.03	2.58	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	184.42	2.42	4.23	0.00	0.60	0.60	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	219.61	2.85	3.80	1.27	2.22	1.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	241.49	4.80	3.20	2.13	1.07	1.07	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	169.53	4.60	3.45	0.00	0.00	1.15	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	212.89	2.57	3.60	1.03	1.54	2.06	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	178.25	2.12	1.41	0.71	0.71	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	157.76	3.40	4.54	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	185.13	3.74	2.50	1.66	1.66	2.08	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	147.21	3.13	0.78	1.57	0.00	5.48	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	139.46	2.09	2.92	0.00	0.00	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	166.80	1.86	0.00	0.00	1.86	1.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	112.40	2.01	2.01	1.34	0.00	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	106.39	1.60	2.67	0.00	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	135.78	3.23	1.62	0.40	0.81	1.21	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	104.62	0.00	0.92	0.00	0.00	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	95.13	2.67	3.56	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	115.68	1.71	0.57	1.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	88.96	1.53	1.53	0.00	0.77	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	91.93	0.55	2.74	0.00	0.55	0.55	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	93.54	0.00	1.34	0.45	0.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	95.92	2.08	1.04	0.26	0.00	0.26	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	87.53	0.66	1.33	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	106.01	0.00	0.00	2.08	6.24	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	186.43	0.68	1.37	1.37	0.23	0.91	0.91	0.91
Macrophage - monocyte derived, donor2	11313-117C8	121.30	0.55	0.92	0.37	0.18	0.73	0.37	0.18
Macrophage - monocyte derived, donor3	11389-118C3	120.07	0.52	0.79	1.84	0.66	0.66	0.92	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	134.35	3.19	0.53	2.12	0.00	0.53	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	226.11	4.91	0.63	0.16	0.48	0.32	0.00	2.38
Mallassez-derived cells, donor3	11930-125I4	272.97	5.14	1.39	0.69	0.42	0.28	0.14	1.53
Mammary Epithelial Cell, donor1	11273-116H4	193.11	1.59	1.00	1.20	0.90	0.60	0.00	0.50
Mammary Epithelial Cell, donor2	11350-117G9	186.47	1.74	1.16	0.58	1.16	0.87	0.29	0.87
Mammary Epithelial Cell, donor3	11422-118F9	57.37	0.00	0.00	0.00	0.00	0.50	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	1240.62	57.62	4.07	0.00	0.68	0.68	0.00	1.36
Mast cell, donor1	11563-120D6	535.62	7.68	6.38	3.68	2.49	4.22	0.65	3.14
Mast cell, donor2	11565-120D8	1120.35	22.88	7.43	2.38	1.78	1.78	2.38	6.54
Mast cell, donor3	11566-120D9	1092.98	14.63	11.48	5.18	3.38	2.93	4.95	6.75
Mast cell, donor4	11567-120E1	1021.36	24.82	6.74	2.30	1.77	1.42	3.19	4.79
Mast cell, expanded and stimulated, donor5	11940-126A5	652.72	2.55	12.09	1.89	1.66	3.22	1.44	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	277.25	0.58	8.17	0.58	1.75	2.33	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	444.78	1.72	13.88	3.67	2.06	2.64	1.03	2.87
Mast cell, expanded, donor8	11941-126A6	448.71	2.18	8.54	2.01	1.67	2.01	1.51	3.18
Melanocyte - dark, donor1	11502-119F8	153.62	0.70	0.20	0.30	0.10	0.20	0.20	0.90
Melanocyte - dark, donor2	11582-120F7	100.71	1.73	0.35	1.38	0.35	0.69	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	236.52	5.14	3.26	0.43	1.09	1.45	0.51	1.38
Melanocyte - light, donor1	11274-116H5	90.03	1.18	0.47	0.24	0.47	0.71	0.00	0.71
Melanocyte - light, donor2	11351-117H1	51.87	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	39.89	1.73	0.00	0.87	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	165.14	0.94	1.25	0.73	0.62	1.04	0.21	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	185.03	1.88	2.42	1.34	2.69	1.88	1.08	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	289.55	2.95	1.07	0.80	1.87	1.87	0.80	1.87
Meningeal Cells, donor1	11493-119E8	117.86	0.62	4.47	0.00	0.12	0.25	0.00	1.98
Meningeal Cells, donor2	11573-120E7	129.40	0.88	2.64	0.00	0.44	0.00	0.44	1.76
Meningeal Cells, donor3	11654-122E7	148.01	0.90	0.24	0.24	0.41	0.33	0.08	1.30
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	166.25	1.14	0.57	0.29	0.29	0.57	0.29	2.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	169.16	5.53	1.71	0.81	0.50	0.30	0.20	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	23.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	41.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	143.52	2.15	1.44	0.72	0.00	1.44	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	148.87	0.85	1.69	0.64	1.06	0.42	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	123.65	0.00	1.01	3.02	0.50	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	66.80	0.44	0.22	0.44	0.44	0.22	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	56.99	0.00	0.73	0.00	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	53.61	0.00	0.41	0.20	0.20	0.00	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	183.11	5.82	6.23	0.14	0.28	0.00	0.00	1.52
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	41.63	0.00	0.00	0.37	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	192.36	2.63	0.79	0.53	0.26	0.66	0.26	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	77.75	0.30	0.30	0.30	0.00	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	30.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	75.57	0.64	1.28	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	182.18	0.35	0.35	0.00	0.35	0.35	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	168.87	3.44	0.00	0.63	0.63	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	158.20	0.73	2.18	0.73	1.45	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	172.63	1.86	2.92	1.06	1.33	0.80	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	91.59	1.50	0.00	0.50	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	147.85	1.73	0.65	1.30	1.52	1.16	0.36	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	141.78	1.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	185.94	0.74	2.71	1.23	0.99	0.49	1.48	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	166.96	2.06	2.94	0.88	0.00	0.59	1.18	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	58.77	0.00	0.00	0.00	0.00	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	154.66	1.24	3.72	2.48	0.31	0.62	2.17	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	131.51	1.66	1.87	1.04	1.66	0.62	1.04	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	48.64	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	183.69	2.25	2.75	1.75	0.75	0.75	0.75	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	205.28	2.79	1.86	0.47	0.93	0.00	1.86	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	173.55	2.85	3.05	0.41	0.81	0.41	1.02	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	144.53	0.79	3.17	0.79	0.00	0.40	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	94.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	107.96	2.65	4.42	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	140.58	1.90	1.14	0.38	1.14	0.38	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	85.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	158.53	2.33	2.97	0.85	0.21	0.85	1.06	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	122.47	0.92	0.92	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	132.34	2.38	3.58	0.30	0.30	0.30	1.49	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	150.90	0.00	1.68	0.00	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	197.21	6.02	3.26	1.51	0.50	1.00	1.51	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	143.55	2.85	2.38	0.24	0.71	0.48	1.43	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	128.27	4.98	1.66	0.55	0.00	0.00	1.11	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	199.62	4.60	0.69	0.69	0.92	0.23	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	158.60	2.94	2.10	0.21	0.84	0.63	1.26	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	174.48	2.65	1.22	0.41	0.00	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	202.52	2.79	1.07	3.00	1.07	1.07	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	144.04	2.67	0.89	0.89	0.44	0.67	0.89	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	173.90	2.41	0.44	1.31	1.10	0.44	0.88	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	137.39	2.53	0.51	0.51	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	87.82	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	203.30	2.72	0.00	0.54	0.00	0.27	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	139.98	2.65	1.47	0.29	0.29	0.29	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	87.23	2.18	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	93.71	0.00	0.48	0.96	0.00	0.48	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	134.08	2.40	2.00	1.20	0.40	0.00	1.60	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	111.07	1.37	0.00	1.37	1.37	0.00	6.86	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	80.59	1.50	0.00	1.50	0.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	188.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	156.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	148.02	0.00	1.31	0.00	1.75	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	107.05	0.00	0.00	1.10	0.00	1.10	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	140.89	0.64	0.64	0.00	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	168.83	1.74	0.74	0.50	0.74	0.74	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	99.51	1.39	0.00	0.00	0.70	0.00	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	132.59	2.21	0.00	0.00	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	144.61	1.03	0.00	1.71	0.34	0.00	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	112.90	1.31	1.31	1.75	0.00	0.00	1.31	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	145.23	0.36	0.36	0.00	0.71	0.00	0.36	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	139.43	1.68	1.40	1.96	1.68	0.28	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	120.53	2.49	0.00	0.42	0.83	0.00	0.83	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	124.71	0.58	0.58	0.00	0.00	0.00	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	103.77	1.81	1.51	0.60	0.60	1.21	0.90	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	128.56	1.25	5.43	0.42	0.42	0.83	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	136.69	2.77	1.85	1.85	0.92	0.00	2.77	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	153.66	2.28	2.85	1.71	0.57	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	181.71	2.07	0.28	0.28	0.28	0.14	0.55	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	129.06	1.55	1.81	1.81	0.78	0.52	1.55	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	190.04	3.00	1.72	0.43	1.29	1.29	2.57	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	132.76	0.00	0.00	0.64	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	144.65	1.33	0.53	0.80	1.87	0.00	2.94	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	269.10	2.99	3.89	2.69	1.20	1.50	2.99	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	173.32	1.55	0.57	0.28	0.57	0.71	0.57	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	140.15	0.96	2.87	1.91	0.96	0.32	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	213.17	2.65	2.65	1.11	1.33	1.11	2.21	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	189.98	0.76	0.38	0.76	0.38	0.00	0.76	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	179.84	2.56	0.85	2.27	1.14	0.57	2.56	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	195.17	2.70	4.18	2.46	2.21	0.74	0.49	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	196.15	1.30	1.30	1.30	0.00	0.00	1.30	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	190.53	1.18	1.47	1.76	0.88	1.76	3.82	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	232.68	2.59	4.32	2.02	0.00	0.86	1.15	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	284.38	4.53	1.65	0.00	2.47	0.41	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	203.98	0.60	2.38	1.79	0.89	0.30	3.28	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	184.58	3.77	0.00	3.77	7.53	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	139.02	1.78	1.78	1.78	1.78	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	202.40	0.33	0.33	0.33	1.64	0.33	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	157.79	2.10	0.00	1.05	2.10	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	179.10	1.19	2.17	2.57	1.19	0.40	0.59	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	189.99	0.93	2.79	0.93	1.86	0.93	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	173.49	0.38	0.38	1.13	0.00	1.88	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	108.67	0.27	0.27	1.07	0.80	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	254.82	1.13	0.11	0.45	0.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	132.61	0.00	0.00	0.00	0.74	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	187.24	1.83	0.00	1.47	0.73	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	183.56	1.56	6.22	6.22	4.67	7.78	3.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	198.81	2.14	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	104.33	0.00	0.00	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	116.14	2.02	1.01	2.02	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	110.05	0.84	0.42	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	193.40	5.45	0.00	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	51.50	1.91	0.64	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	67.22	3.24	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	95.16	4.53	0.00	3.02	0.00	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	593.86	45.68	0.00	0.00	5.71	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	446.96	35.89	3.26	3.26	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	209.11	9.50	0.00	0.00	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	426.67	25.10	37.65	37.65	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	104.06	1.29	1.29	1.08	0.43	0.00	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	124.38	0.52	0.52	0.52	3.66	1.57	1.57	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	62.08	0.67	1.33	2.00	0.00	0.00	0.67	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	49.25	0.00	1.25	0.00	0.00	0.00	1.67	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	182.73	0.57	0.95	0.57	1.14	0.38	1.52	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	314.38	0.00	0.00	1.60	0.00	0.00	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	38.76	0.00	2.72	0.68	0.00	0.00	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	690.95	1.84	0.00	0.00	1.84	1.84	0.00	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	77.01	0.00	2.51	0.84	0.00	0.42	4.60	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	97.62	0.46	0.46	0.23	0.00	0.23	0.23	2.32
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	70.80	0.00	1.62	1.35	0.81	0.27	2.97	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	197.83	0.42	4.41	1.68	1.26	0.21	2.94	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	2683.47	11.13	0.00	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	83.39	2.48	0.99	0.99	0.50	0.00	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	166.73	0.54	1.08	2.17	3.25	0.81	0.54	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	99.74	0.91	0.91	1.13	1.13	0.23	1.36	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	67.28	0.65	1.63	0.82	0.65	0.33	1.14	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	173.32	0.18	4.56	4.01	0.73	1.09	1.82	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	92.83	0.53	1.06	2.12	0.00	0.00	4.24	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	78.04	0.60	3.60	2.40	1.20	0.60	4.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	310.46	0.98	1.97	2.63	5.25	2.30	1.97	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	82.61	1.46	0.98	1.46	0.49	0.49	1.95	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	179.73	0.53	5.29	1.76	1.59	1.06	4.41	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	87.90	3.52	0.00	0.70	2.11	0.00	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	108.03	0.46	0.46	4.60	1.38	1.38	4.60	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	108.94	0.32	0.96	1.29	0.96	0.96	2.89	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	291.09	7.59	4.14	3.45	8.28	2.76	1.03	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	955.75	0.00	10.11	2.53	7.59	2.53	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	175.33	0.89	3.56	1.56	0.67	0.89	3.12	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	88.49	0.00	1.69	2.54	0.85	1.69	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	159.74	0.47	2.37	3.32	1.66	1.19	4.03	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	103.02	0.43	2.15	0.86	1.29	1.29	3.00	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	2879.86	36.11	27.08	0.00	9.03	27.08	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	101.30	1.67	3.33	0.33	1.00	1.00	1.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	134.81	0.00	1.35	1.35	0.00	1.35	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	70.63	0.79	0.79	2.38	1.19	0.00	2.38	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	110.51	0.93	8.36	5.57	0.93	0.93	4.64	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	150.59	0.76	0.76	1.89	0.38	0.38	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	62.57	0.33	1.96	0.98	1.30	0.00	2.28	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	61.88	0.00	3.49	0.87	0.87	0.00	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	175.49	0.45	4.98	1.36	0.45	0.45	1.36	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	73.20	0.88	1.76	0.88	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	99.73	0.00	1.99	2.66	1.33	0.66	2.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	95.74	0.00	1.49	1.98	0.50	0.00	2.98	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	65.46	0.38	3.06	1.15	1.53	0.00	1.91	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	157.27	0.00	1.51	2.12	2.12	0.60	1.51	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	166.43	3.32	2.43	0.22	0.22	1.33	1.33	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	71.83	0.00	2.03	1.36	0.00	0.00	2.03	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1635.05	0.00	0.00	0.00	15.33	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	93.89	0.00	1.22	1.22	1.22	0.61	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	69.56	0.63	1.26	1.26	0.63	0.63	2.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	82.32	0.61	2.42	3.03	2.12	0.91	4.54	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	80.70	0.00	0.79	0.00	0.00	0.00	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	289.08	2.27	3.40	2.27	5.67	4.53	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1911.88	15.17	10.12	10.12	5.06	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	137.02	1.99	1.12	0.87	2.11	1.12	0.50	1.12
Myoblast, donor2	11322-117D8	139.81	0.77	4.60	1.73	2.11	2.88	1.53	1.73
Myoblast, donor3	11398-118D3	159.25	2.19	2.02	0.50	0.50	0.84	0.50	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	281.94	7.44	2.48	4.38	1.75	2.77	1.75	2.33
Natural Killer Cells, donor1	11230-116C6	1688.88	191.58	14.15	12.61	8.61	9.23	7.07	1.85
Natural Killer Cells, donor2	11311-117C6	1107.01	97.40	35.28	22.92	15.68	10.86	11.16	2.71
Natural Killer Cells, donor3	11387-118C1	1242.73	109.51	11.78	26.50	26.69	12.70	13.25	3.31
Neural stem cells, donor1	11275-116H6	456.22	1.81	2.90	0.00	0.36	1.09	0.36	1.09
Neural stem cells, donor2	11352-117H2	527.63	0.00	5.78	0.00	0.00	1.93	0.00	1.93
Neurons, donor1	11494-119E9	306.09	3.41	1.14	3.41	2.28	4.55	0.00	1.14
Neurons, donor2	11574-120E8	247.68	1.32	1.32	0.66	0.22	0.66	0.00	1.32
Neurons, donor3	11655-122E8	294.34	1.64	2.47	0.82	3.29	1.64	0.82	0.82
Neutrophils, donor1	11233-116C9	2148.33	25.06	2.78	3.71	4.64	7.42	0.00	7.42
Neutrophils, donor2	11314-117C9	1301.60	14.49	17.39	23.19	8.70	20.29	0.00	2.90
Neutrophils, donor3	11390-118C4	2476.97	28.10	2.44	1.83	3.67	6.72	1.22	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	176.20	0.83	0.24	0.47	0.00	0.00	0.12	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	65.45	0.00	0.65	0.00	0.33	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	150.82	1.60	1.00	0.00	0.20	0.20	0.00	0.80
Olfactory epithelial cells, donor1	11933-125I7	198.08	0.69	2.62	2.75	1.79	1.24	0.96	0.69
Olfactory epithelial cells, donor2	11934-125I8	216.39	1.59	2.32	2.89	1.45	1.01	1.30	1.45
Olfactory epithelial cells, donor3	11935-125I9	189.10	0.34	2.27	2.84	1.36	1.02	1.59	0.34
Olfactory epithelial cells, donor4	11936-126A1	154.76	0.29	2.63	0.58	0.68	0.39	0.58	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	151.66	1.20	0.00	0.00	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	64.45	0.00	0.43	0.21	0.00	0.00	0.00	0.64
Osteoblast - differentiated, donor2	11353-117H3	44.58	0.00	2.29	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	62.07	0.62	0.62	1.24	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	66.84	0.39	0.39	0.39	0.20	0.39	0.00	0.00
Osteoblast, donor2	11354-117H4	185.41	0.70	0.70	0.00	0.00	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	88.51	0.89	0.53	0.36	0.00	0.00	0.00	0.89
Pancreatic stromal cells, donor1	11249-116E7	199.47	0.84	0.76	2.19	1.85	1.26	0.42	0.84
Pericytes, donor1	11491-119E6	37.16	0.00	1.22	0.00	0.00	0.00	0.00	0.22
Pericytes, donor2	11571-120E5	42.10	0.23	0.23	0.00	0.00	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	54.73	0.61	0.81	0.00	0.41	0.41	0.41	0.81
Perineurial Cells, donor1	11499-119F5	183.09	1.13	1.13	1.02	1.02	0.68	0.34	1.36
Perineurial Cells, donor2	11579-120F4	132.68	2.21	0.18	0.28	0.09	0.37	0.00	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	1280.70	60.88	7.01	5.42	2.87	2.55	0.96	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	945.66	49.46	14.69	12.98	10.53	7.10	9.79	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1052.93	54.10	4.92	9.32	7.38	5.69	6.34	0.91
Placental Epithelial Cells, donor1	11278-116H9	86.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	44.36	0.00	1.11	0.00	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	80.49	0.00	0.20	0.20	0.39	0.20	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	27.85	0.95	0.00	0.00	0.00	0.00	0.00	1.27
Preadipocyte - breast, donor1	11467-119B9	101.48	0.94	2.25	0.19	0.94	0.38	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	276.85	3.65	5.22	2.22	2.22	2.87	0.91	1.04
Preadipocyte - breast, donor2	11328-117E5	94.79	1.13	5.63	1.58	0.68	2.03	0.00	1.35
Preadipocyte - omental, donor1	11468-119C1	126.80	2.24	2.56	0.85	0.64	0.85	0.75	0.21
Preadipocyte - omental, donor2	11329-117E6	142.29	2.18	1.31	0.44	0.44	0.87	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	103.00	1.29	0.86	2.44	1.00	1.43	0.72	0.29
Preadipocyte - perirenal, donor1	11469-119C2	81.69	0.98	0.00	0.00	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	66.95	1.54	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	158.84	1.24	1.59	0.53	0.71	0.89	0.00	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	189.19	0.68	0.34	0.17	0.51	0.51	0.17	0.51
Preadipocyte - visceral, donor1	11280-116I2	227.09	2.51	1.40	0.47	0.84	0.56	0.09	0.47
Preadipocyte - visceral, donor2	11357-117H7	142.20	1.38	0.92	1.38	0.92	0.00	0.46	0.92
Preadipocyte - visceral, donor3	11429-118G7	121.73	1.78	2.61	0.21	0.21	0.31	0.00	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	287.22	1.81	1.96	1.96	1.81	1.81	0.45	0.15
Prostate Epithelial Cells, donor2	11331-117E8	104.27	1.49	4.33	0.54	0.95	0.54	0.68	0.95
Prostate Epithelial Cells, donor3	11404-118D9	108.88	0.43	0.61	0.92	1.16	1.59	0.43	0.00
Prostate Stromal Cells, donor1	11254-116F3	147.05	1.71	0.46	1.37	0.91	0.34	0.11	0.34
Prostate Stromal Cells, donor2	11332-117E9	147.02	0.54	2.51	0.90	2.69	1.08	0.54	1.08
Prostate Stromal Cells, donor3	11405-118E1	156.52	0.83	0.83	1.15	1.98	1.98	0.63	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	44.89	0.36	1.09	0.00	0.00	0.36	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	104.24	0.62	0.21	0.14	0.07	0.42	0.14	0.49
Renal Epithelial Cells, donor1	11517-119H5	54.27	0.51	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	38.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	146.20	0.21	0.11	0.53	0.32	0.42	0.21	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	25.87	0.68	0.00	0.00	0.00	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	68.46	0.94	2.70	0.00	0.27	0.00	0.27	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	132.10	1.78	0.67	0.67	0.44	1.11	0.22	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	29.94	0.00	0.67	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	61.62	0.66	0.88	0.44	0.00	0.22	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	47.02	0.00	1.88	0.00	0.00	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	29.41	0.28	0.00	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	98.51	0.27	1.34	0.27	0.27	0.54	0.54	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	40.90	0.00	0.42	1.27	0.42	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	54.96	0.00	0.77	0.19	0.39	0.96	0.19	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	198.61	1.30	1.04	0.26	0.78	0.26	0.00	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	166.00	1.14	2.84	0.28	1.14	0.85	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	48.37	0.00	0.00	1.03	0.00	1.03	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	167.86	2.51	2.51	0.25	0.00	0.00	0.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	507.01	8.02	3.88	4.54	4.28	1.07	2.67	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	258.19	1.79	0.89	2.68	5.36	3.57	6.25	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	599.35	3.85	1.10	3.30	2.75	3.85	1.10	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	502.91	1.16	1.16	2.90	0.58	4.64	2.90	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	268.11	1.56	7.15	0.13	0.13	0.39	0.13	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	173.88	0.89	2.98	0.89	0.79	1.39	1.39	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	248.06	2.79	2.45	0.45	1.67	0.45	0.33	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	276.12	3.10	5.33	0.12	0.12	0.50	0.12	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	173.07	1.28	2.68	1.40	1.17	0.82	0.35	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	231.59	2.08	1.85	1.85	1.62	1.16	0.69	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	204.27	1.92	5.89	0.14	0.82	0.14	0.41	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	170.79	1.06	0.61	0.30	0.15	0.45	0.76	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	211.98	1.25	0.18	0.36	0.72	0.36	0.36	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	206.29	1.29	7.32	0.29	0.57	0.57	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	167.63	1.29	0.86	0.97	0.43	0.54	0.97	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	215.74	0.89	1.11	1.11	0.00	0.89	1.11	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	241.07	1.34	7.65	0.57	0.19	0.57	0.19	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	200.95	1.58	0.93	1.40	0.56	0.47	1.30	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	307.23	3.01	1.69	1.50	0.38	0.94	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	241.00	1.99	6.90	0.00	0.40	0.27	0.13	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	229.63	1.46	0.68	0.88	0.68	0.49	0.58	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	270.59	1.91	2.86	2.10	1.34	1.53	1.53	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	206.97	1.07	4.59	0.11	0.21	0.64	0.00	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	185.00	0.84	1.96	0.56	1.12	1.12	1.12	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	251.73	2.22	2.73	0.85	1.54	0.68	0.68	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	225.72	1.28	5.65	0.00	0.55	0.18	0.73	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	216.32	0.98	2.33	0.86	0.74	0.61	0.49	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	258.30	3.22	2.15	1.61	0.81	0.67	0.54	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	197.90	1.89	11.32	0.24	0.94	0.47	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	249.80	1.79	0.79	0.99	0.20	0.60	0.99	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	264.48	1.87	3.04	0.94	1.17	1.64	1.17	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	199.27	1.45	8.29	0.00	0.00	0.83	0.21	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	260.59	2.88	1.99	1.11	0.44	1.11	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	234.16	2.09	1.88	1.46	0.21	1.25	0.84	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	191.92	1.48	6.86	0.00	0.67	0.81	0.40	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	244.71	1.87	1.53	1.36	0.34	0.17	2.55	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	234.05	2.70	3.47	1.35	0.58	1.16	1.93	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	148.73	0.86	8.94	0.17	0.34	0.52	0.34	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	165.01	0.82	1.65	1.37	1.51	0.41	2.19	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	179.77	2.13	4.10	2.13	1.97	0.33	1.64	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	185.09	1.02	5.79	0.00	0.68	0.51	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	213.06	1.33	1.04	0.74	0.74	0.89	1.18	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	194.05	1.07	1.33	1.33	1.07	0.80	2.67	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	222.06	1.38	7.47	0.14	0.69	0.14	0.14	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	191.91	0.71	2.38	0.24	1.19	0.71	1.19	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	293.44	1.21	1.01	1.81	1.01	1.01	2.62	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	186.65	1.13	5.65	0.19	0.47	0.66	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	200.18	1.05	4.19	2.45	1.05	1.40	1.75	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	220.92	1.81	3.63	0.91	2.12	0.91	5.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	241.35	1.22	10.40	0.24	0.61	0.73	0.12	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	671.58	4.22	4.08	2.18	3.06	1.02	1.75	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	256.76	1.83	1.22	1.83	1.83	0.00	2.43	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	267.04	0.60	10.55	1.21	0.60	0.90	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	236.37	2.26	3.17	2.04	2.04	1.36	0.90	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	335.49	1.80	3.59	3.00	2.70	3.00	1.50	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	315.14	2.60	14.52	0.00	0.12	0.24	0.12	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	239.91	1.28	2.77	1.71	0.21	0.64	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	360.59	1.80	7.81	1.20	1.80	1.80	2.40	0.00
Schwann Cells, donor1	11498-119F4	41.94	0.38	0.19	0.00	0.38	0.00	0.00	1.13
Schwann Cells, donor2	11578-120F3	98.67	0.00	0.00	0.00	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	68.35	0.44	0.22	0.22	0.22	0.44	0.00	1.10
Sebocyte, donor1	11220-116B5	152.28	5.48	0.00	0.00	0.00	0.00	0.00	2.19
Sebocyte, donor2	11301-117B5	135.11	2.76	0.00	0.46	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	53.38	0.00	0.00	0.00	0.21	0.00	0.00	0.21
Sertoli Cells, donor1	11255-116F4	183.88	4.97	0.00	4.97	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	146.87	2.82	11.30	5.65	8.47	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	160.38	0.44	1.32	0.70	0.35	0.53	0.18	0.62
Skeletal Muscle Cells, donor2	11358-117H8	38.31	0.00	1.45	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	71.90	0.00	1.67	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	182.86	0.63	5.03	0.63	1.10	0.63	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	175.55	1.93	5.20	0.30	0.45	0.45	0.15	0.74
Skeletal Muscle Cells, donor6	11459-119B1	190.99	1.23	3.23	0.00	0.46	0.00	0.00	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	283.01	1.26	1.51	2.02	2.14	1.01	1.01	1.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	189.92	0.29	3.28	1.43	1.57	1.14	0.57	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	210.72	1.49	1.19	1.98	1.59	1.09	0.60	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	176.84	1.77	0.67	0.25	0.25	0.42	0.08	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	52.11	0.00	0.00	0.00	0.00	1.45	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	63.43	0.00	1.38	0.14	0.14	0.14	0.00	0.14
Skin - palm, donor1	10286-104F7	870.30	5.37	0.00	5.37	0.00	2.69	10.74	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	37.19	0.29	0.00	0.29	0.43	0.14	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	1201.48	21.27	23.72	16.36	16.36	11.45	4.91	7.36
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	35.83	0.39	0.26	0.00	0.13	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	156.94	2.78	1.67	2.50	1.53	0.83	0.70	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	158.24	1.69	2.11	1.27	0.84	0.42	3.52	1.83
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1316.04	17.55	19.66	12.26	5.50	8.67	3.81	5.71
Small Airway Epithelial Cells, donor3	11406-118E2	123.22	0.82	0.52	1.80	0.75	0.97	2.92	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	101.83	0.93	0.00	0.00	0.00	0.00	0.00	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	198.76	7.56	10.00	0.67	0.67	0.22	0.22	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	72.30	0.59	0.00	0.00	0.59	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	57.02	0.88	0.44	0.00	0.22	0.00	0.00	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	48.43	0.79	0.00	0.00	0.39	0.00	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	82.66	0.77	0.77	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	236.18	0.00	5.00	3.00	3.00	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	52.17	0.93	0.53	0.27	0.13	0.00	0.13	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	144.52	1.77	2.66	1.99	1.11	1.11	0.89	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	63.38	1.15	1.66	0.26	0.38	0.26	0.26	1.28
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	131.54	1.30	0.65	0.98	0.00	0.33	0.33	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	132.01	1.48	0.59	0.30	0.59	0.00	0.30	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	103.64	1.71	0.28	0.57	0.85	1.00	0.43	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	26.68	0.00	0.16	0.16	0.00	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	118.12	0.30	0.30	1.52	1.83	0.61	1.22	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	58.59	0.51	0.00	0.51	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	37.19	1.43	0.95	0.48	0.48	0.00	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	135.82	0.44	0.44	0.88	0.88	0.44	0.15	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	128.28	0.86	1.08	1.72	0.65	0.65	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	152.08	0.31	0.31	0.52	0.94	1.05	0.73	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	61.10	0.62	0.15	0.00	0.31	0.00	0.15	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	37.73	3.23	1.08	0.00	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	50.81	0.90	0.60	0.00	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	43.70	0.00	0.00	0.34	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	179.75	0.86	0.86	0.86	1.18	0.63	0.00	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	178.24	2.72	0.81	0.30	0.10	0.60	0.10	4.03
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	147.23	2.28	3.87	2.28	1.14	0.68	1.14	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	70.04	1.81	1.21	0.00	0.00	0.00	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	200.81	1.06	0.26	0.79	0.53	0.00	0.53	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	169.78	1.20	10.65	0.40	0.27	0.40	0.13	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	141.00	1.13	3.76	2.25	1.63	1.38	0.63	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	145.09	1.01	0.25	0.25	0.00	0.76	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	78.10	0.60	0.30	0.15	0.30	0.00	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	52.51	0.00	0.00	0.75	0.00	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	253.27	0.00	1.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	76.27	1.40	0.00	0.00	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	109.56	3.03	2.02	1.01	1.51	0.50	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	47.64	2.19	0.94	0.31	0.00	0.31	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.66	0.00	0.00	0.29	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	156.62	0.50	0.25	0.25	0.00	0.00	0.25	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	135.48	1.87	0.00	0.93	0.47	0.00	0.00	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	57.42	1.01	0.14	0.00	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	84.14	1.78	0.76	1.53	0.00	0.76	0.25	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	40.24	0.38	0.75	0.19	0.00	0.38	0.38	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	186.28	2.93	0.42	0.28	0.14	0.14	0.00	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	98.12	0.67	0.08	0.08	0.08	0.17	0.00	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	24.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	52.11	1.22	0.24	0.00	0.24	0.24	0.24	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	169.03	2.43	5.74	0.22	0.66	0.88	0.44	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	120.54	0.29	0.00	0.59	0.59	0.29	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	162.49	2.33	1.55	1.75	2.72	0.58	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	92.56	0.53	0.53	1.85	1.06	0.53	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	282.31	5.95	3.72	3.72	2.60	2.60	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	166.37	2.16	0.36	1.44	1.80	0.72	1.80	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	103.91	0.85	0.28	0.57	1.14	0.00	0.85	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	136.67	0.79	0.79	2.36	0.79	0.39	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	180.31	3.30	1.78	1.52	1.27	0.51	0.51	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	154.94	3.19	2.40	3.19	3.59	2.00	1.20	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	174.73	3.34	2.51	2.09	2.93	0.84	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	169.14	0.00	1.38	1.83	2.29	0.92	0.00	0.92
Synoviocyte, donor1	11291-117A4	171.86	1.51	1.18	0.34	0.34	1.18	0.00	1.01
Synoviocyte, donor2	11368-117I9	281.61	3.86	1.84	2.85	2.01	1.17	1.34	0.00
Synoviocyte, donor3	11440-118H9	170.01	1.12	9.38	0.45	1.12	1.34	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	73.97	0.36	0.71	0.00	0.36	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	43.60	0.00	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	52.10	0.00	0.69	0.46	0.00	0.23	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	69.46	0.07	0.50	0.22	0.07	0.36	0.00	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	56.05	0.39	0.39	0.39	0.77	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	41.23	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	507.23	5.41	4.43	5.17	3.94	1.72	1.85	1.60
Urethra, donor2	10319-105A4	715.77	5.40	17.98	14.39	5.40	25.18	34.17	1.80
Urothelial Cells, donor1	11520-119H8	40.38	0.00	0.00	0.00	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	42.46	0.40	0.00	0.40	0.80	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	29.11	0.23	0.46	0.00	0.00	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	147.11	0.67	0.22	1.11	0.67	0.00	0.45	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	796.36	0.89	19.58	0.00	1.78	1.78	0.89	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	800.58	1.43	47.18	1.43	1.43	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	446.31	2.05	7.53	3.42	4.11	2.74	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	762.71	1.72	6.20	4.82	7.92	6.89	2.07	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	719.89	0.58	9.88	3.49	4.07	1.74	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	729.91	3.12	21.87	1.04	1.04	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	747.08	2.75	34.88	0.92	1.84	0.00	0.92	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	443.67	0.91	12.78	3.65	6.39	2.74	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	330.48	5.18	2.22	3.58	1.36	1.97	2.10	1.48
Wilms' tumor cell line:HFWT	10597-108E3	240.25	2.64	0.88	1.76	0.88	0.00	3.52	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	289.93	5.03	3.35	2.79	0.28	2.51	4.75	1.68
achilles tendon, donor2	10292-104G4	700.55	6.20	8.27	12.40	12.40	10.33	20.67	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	454.84	3.06	2.55	6.63	6.63	4.84	1.78	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	630.82	7.43	4.88	3.25	2.55	2.55	0.93	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	719.49	9.14	5.94	2.97	3.32	3.21	1.31	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	446.81	7.89	5.71	3.54	3.54	3.81	3.54	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	319.87	0.56	4.22	2.81	3.94	3.65	1.12	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	455.32	3.60	0.85	1.69	1.27	0.63	0.21	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	420.84	2.18	12.52	7.62	5.99	2.45	3.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	467.08	1.32	4.41	0.88	0.88	3.53	1.76	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	700.34	2.86	5.31	3.27	4.90	5.31	2.45	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	561.09	3.88	3.88	7.38	1.94	3.88	3.11	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	126.41	0.74	0.74	0.37	0.74	1.66	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	745.00	0.00	31.20	19.50	11.70	3.90	42.91	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	490.79	4.42	2.09	1.63	1.63	1.16	0.70	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	467.84	4.40	4.92	2.59	2.07	3.11	1.04	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	417.32	1.75	7.89	4.09	3.51	4.38	2.63	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	441.06	4.18	7.90	4.65	2.79	2.32	3.72	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	411.25	4.52	10.69	1.23	4.11	1.65	1.65	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	110.20	0.92	0.00	1.23	0.31	0.31	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	369.53	1.71	0.00	0.43	0.85	1.28	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	341.81	2.12	0.30	0.61	0.91	0.61	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	342.52	3.61	1.20	0.48	0.24	0.48	0.00	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	245.46	2.00	2.45	1.11	1.11	2.90	1.11	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	487.31	6.67	9.01	3.00	1.00	1.67	6.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	665.24	3.72	1.86	1.86	0.00	1.86	7.43	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	387.96	4.52	8.29	4.90	4.14	2.26	3.01	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	566.10	3.93	4.80	2.62	1.74	1.74	4.36	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	667.31	13.12	9.37	3.75	1.87	1.87	37.49	3.75
adenocarcinoma cell line:IM95m	10796-110I4	239.03	1.65	1.18	1.18	0.47	1.41	3.77	0.47
adipose tissue, adult, pool1	10010-101C1	187.69	0.78	1.09	0.31	0.62	0.47	0.31	0.93
adipose, donor1	10184-103D4	1620.84	4.10	5.86	11.73	15.25	11.73	4.69	2.35
adipose, donor2	10185-103D5	311.44	0.00	5.27	10.95	14.19	3.65	8.52	0.00
adipose, donor3	10186-103D6	432.94	1.91	6.26	11.98	13.61	4.36	4.08	1.36
adipose, donor4	10187-103D7	354.50	2.60	4.33	19.94	21.67	7.80	0.87	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	368.83	3.63	2.53	1.26	0.95	1.42	4.73	1.42
adrenal gland, adult, pool1	10081-102A9	294.65	3.64	10.91	0.00	3.64	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	269.08	2.00	2.13	2.67	1.33	0.53	0.53	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	270.48	2.86	1.43	2.50	0.71	1.07	2.50	1.07
amniotic membrane cells, donor1	12235-129G3	260.14	3.25	1.16	2.09	0.23	0.70	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	251.55	1.01	2.70	1.01	1.01	0.34	0.34	1.35
amniotic membrane cells, donor3	12237-129G5	310.22	0.59	14.73	0.29	0.59	2.36	0.59	0.29
amygdala - adult, donor10196	10167-103B5	608.31	13.04	4.74	4.74	5.93	11.86	3.56	1.19
amygdala, adult, donor10252	10151-102I7	658.39	5.47	11.96	25.55	4.66	9.94	8.72	1.22
amygdala, newborn, donor10223	10360-105E9	217.87	5.81	1.61	6.46	3.23	0.65	4.20	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	493.40	5.86	2.67	2.93	2.16	2.29	1.15	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	260.11	2.21	1.99	4.85	2.65	2.65	3.75	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	808.70	15.37	10.69	20.71	13.36	7.68	21.04	1.34
aorta, adult, pool1	10052-101G7	351.67	1.37	0.98	2.35	3.33	1.57	1.96	0.20
appendix, adult	10189-103D9	599.64	1.94	11.64	8.93	4.66	0.78	10.09	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	549.95	3.44	9.29	7.22	5.50	3.10	3.78	1.38
artery, adult	10190-103E1	354.62	2.72	5.43	1.36	1.36	2.72	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	373.61	4.49	1.45	2.75	1.88	0.87	1.01	1.74
b cell line:RPMI1788	10427-106D4	328.48	5.65	2.53	1.34	1.19	0.89	0.45	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	172.57	1.39	0.28	0.83	0.55	1.94	0.28	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	363.09	8.53	2.08	1.09	0.89	0.60	0.50	4.66
bile duct carcinoma cell line:TFK-1	10496-107C1	361.70	4.02	2.18	2.34	2.18	0.33	2.34	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	307.58	1.12	1.68	1.12	2.24	2.80	0.56	0.00
bladder, adult, pool1	10011-101C2	262.04	0.98	1.20	1.20	0.87	0.54	1.20	0.54
blood, adult, pool1	10053-101G8	522.65	4.43	2.21	0.00	0.00	2.21	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	275.74	0.00	0.00	0.86	0.00	0.00	0.86	3.43
bone marrow, adult	10192-103E3	257.11	1.35	7.42	0.67	0.67	0.67	0.67	0.67
brain, adult, donor1	10084-102B3	301.37	2.05	4.10	10.25	2.05	2.05	2.05	0.00
brain, adult, pool1	10012-101C3	340.98	3.56	1.11	1.34	0.67	1.34	0.33	0.67
brain, fetal, pool1	10085-102B4	304.54	0.00	0.00	8.01	2.67	0.00	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	560.63	6.28	9.25	4.29	4.96	5.62	19.49	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	786.38	9.86	2.25	1.87	1.37	1.62	3.62	3.12
breast, adult, donor1	10080-102A8	142.69	0.00	1.26	2.53	1.89	0.00	2.53	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	217.62	1.02	1.52	2.41	1.02	1.52	1.40	2.54
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	415.90	4.02	7.11	3.71	4.02	3.09	8.97	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	478.17	4.14	11.74	3.22	4.37	4.14	2.99	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	228.05	4.60	5.57	4.60	2.42	1.94	7.99	0.48
carcinoid cell line:NCI-H1770	10703-109H1	149.98	0.00	5.64	6.11	2.35	4.23	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	198.96	1.42	0.98	0.66	0.22	1.09	0.33	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	294.71	2.22	2.54	3.80	2.22	2.85	3.17	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	394.21	3.99	5.86	3.19	3.19	1.06	3.73	0.53
caudate nucleus - adult, donor10196	10177-103C6	815.14	5.76	5.76	10.36	8.06	9.21	4.61	0.00
caudate nucleus, adult, donor10252	10164-103B2	589.99	3.85	9.37	9.04	4.18	5.19	2.18	0.33
caudate nucleus, adult, donor10258	10379-105H1	310.24	1.53	5.35	2.29	2.29	3.82	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	273.58	7.69	2.20	4.39	2.56	1.83	5.49	1.10
cerebellum - adult, donor10196	10173-103C2	1683.87	2.91	8.74	8.74	11.65	14.57	17.48	0.00
cerebellum, adult, donor10252	10166-103B4	1505.04	5.34	22.63	24.34	6.19	14.73	12.81	4.27
cerebellum, adult, pool1	10083-102B2	382.89	1.38	3.45	5.52	3.79	4.14	1.72	0.69
cerebellum, newborn, donor10223	10357-105E6	1139.15	6.64	3.32	5.81	9.13	13.28	2.49	4.15
cerebral meninges, adult	10188-103D8	264.24	2.52	3.28	16.39	4.79	1.76	7.56	1.01
cerebrospinal fluid, donor2	10294-104G6	338.40	1.46	5.85	5.85	1.46	7.31	4.39	2.19
cervical cancer cell line:D98-AH2	10552-107I3	696.77	5.18	8.05	5.90	5.32	3.16	1.87	0.72
cervical cancer cell line:ME-180	10553-107I4	722.69	18.23	5.80	5.80	5.14	3.81	4.31	0.66
cervix, adult, pool1	10013-101C4	503.95	1.99	4.51	3.88	2.31	1.47	1.78	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	297.07	8.50	1.81	1.81	1.53	0.28	0.70	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	184.18	0.00	0.00	0.00	0.00	0.00	0.00	2.61
choriocarcinoma cell line:BeWo	10423-106C9	498.97	8.20	1.74	3.73	2.11	2.11	1.12	1.24
choriocarcinoma cell line:SCH	10785-110H2	266.51	3.57	2.96	5.30	5.05	3.08	2.96	1.48
choriocarcinoma cell line:T3M-3	10618-108G6	246.19	4.51	5.22	3.56	2.85	1.19	4.98	0.95
chorionic membrane cells, donor1	12238-129G6	341.90	5.41	5.70	0.57	2.85	1.99	0.57	1.14
chorionic membrane cells, donor2	12239-129G7	176.19	2.19	1.79	0.50	0.40	0.89	0.10	0.70
chorionic membrane cells, donor3	12240-129G8	470.91	8.79	35.17	3.85	3.85	7.14	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	259.52	10.10	4.04	3.03	6.06	2.02	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	318.50	1.34	1.15	1.73	1.73	1.15	1.34	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	519.31	4.22	1.90	5.28	2.32	2.32	5.91	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	204.41	0.51	1.03	1.54	1.54	0.51	1.80	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	225.67	0.73	0.73	1.21	1.94	0.97	2.42	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	222.14	0.81	0.41	0.81	1.43	0.41	1.43	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	354.82	1.77	2.06	3.83	2.06	1.47	2.06	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	991.16	17.20	4.43	1.04	2.09	2.35	2.87	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	199.32	3.66	2.97	5.71	4.57	0.91	1.37	0.23
clear cell carcinoma cell line:TEN	10636-108I6	551.06	6.42	3.82	4.34	2.95	2.08	1.21	1.04
colon carcinoma cell line:CACO-2	10513-107D9	366.27	5.49	3.11	1.10	1.46	0.55	1.10	0.55
colon carcinoma cell line:COLO-320	10420-106C6	554.54	4.18	1.52	0.38	0.76	1.14	0.76	0.76
colon, adult, donor1	10082-102B1	371.29	0.00	4.76	7.14	1.19	3.57	2.38	0.00
colon, adult, pool1	10014-101C5	418.19	1.53	2.47	1.88	1.06	0.59	1.41	0.94
colon, fetal, donor1	10070-101I7	370.18	0.62	10.51	24.72	8.03	1.24	29.05	0.00
common myeloid progenitor CMP, donor1	12130-128D6	747.11	36.67	0.00	0.00	0.00	0.00	0.00	9.17
common myeloid progenitor CMP, donor2	12134-128E1	1001.47	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	623.38	16.15	5.95	2.97	2.12	5.10	2.97	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	308.65	6.34	5.43	2.26	1.06	2.26	0.75	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	359.72	7.33	3.53	2.26	2.12	2.96	1.55	0.00
corpus callosum, adult, pool1	10042-101F6	716.55	3.32	4.09	2.87	1.99	1.66	0.44	0.66
cruciate ligament, donor2	10295-104G7	761.84	7.29	10.54	16.21	3.24	4.05	25.12	2.43
diaphragm, fetal, donor1	10069-101I6	357.94	2.41	4.01	6.42	3.21	2.41	6.42	1.61
diencephalon, adult	10193-103E4	320.86	3.36	1.44	4.80	3.60	2.40	4.32	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	434.88	4.36	4.36	5.74	6.89	6.20	0.92	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	387.74	11.03	4.10	2.82	3.59	0.51	2.31	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	332.92	6.98	1.20	2.17	1.20	1.69	1.44	0.48
ductus deferens, adult	10196-103E7	627.41	1.99	14.95	15.45	4.49	3.99	7.48	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	502.64	1.44	2.88	11.52	5.76	4.32	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	549.53	2.94	16.18	8.83	5.89	4.41	3.68	2.21
dura mater, adult, donor1	10041-101F5	420.20	4.87	1.07	0.25	0.50	0.74	0.25	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	201.20	5.11	1.78	1.33	0.67	0.89	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	225.54	1.86	2.58	2.01	1.15	0.72	1.00	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	395.87	3.70	0.00	1.85	1.23	1.23	2.47	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	318.75	2.12	4.84	4.54	2.72	1.51	6.66	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	388.10	2.16	1.23	0.62	0.62	0.31	2.16	0.62
embryonic pancreas cell line:2C6	10603-108E9	478.10	3.94	5.25	0.00	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	393.18	6.37	3.35	1.68	0.67	0.67	4.36	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	337.46	3.99	1.63	3.08	2.36	1.81	1.45	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	192.65	2.73	2.25	1.45	1.61	1.77	0.96	0.80
epidermoid carcinoma cell line:A431	10426-106D3	576.47	11.89	1.45	1.78	2.11	1.00	2.45	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	306.53	8.03	3.08	1.10	1.43	1.32	0.66	3.63
epididymis, adult	10197-103E8	547.98	1.88	11.51	5.65	3.14	2.93	3.98	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	237.02	2.84	1.60	0.89	1.42	2.13	0.89	1.60
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	108.14	1.97	1.57	1.18	1.18	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	281.36	2.49	4.32	2.62	2.75	2.49	0.92	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	322.33	3.64	4.92	3.64	2.46	2.85	1.77	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	271.56	3.47	4.93	4.37	2.91	1.68	1.57	0.90
esophagus, adult, pool1	10015-101C6	215.44	2.34	1.17	1.06	0.74	0.74	0.53	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	535.38	3.51	2.25	1.63	1.88	0.75	0.88	0.38
eye - muscle inferior rectus, donor1	10272-104E2	1074.49	2.41	19.32	50.71	12.07	16.90	31.39	0.00
eye - muscle lateral, donor2	10298-104H1	509.22	6.31	31.56	14.73	14.73	8.42	10.52	0.00
eye - muscle medial, donor2	10299-104H2	632.49	2.98	7.44	11.91	4.46	1.49	34.23	0.00
eye - muscle superior, donor2	10297-104G9	684.46	4.59	20.64	12.61	5.73	17.20	30.96	0.00
eye - vitreous humor, donor1	10268-104D7	463.45	4.37	4.37	7.29	4.37	0.00	7.29	2.91
eye, fetal, donor1	10054-101G9	210.25	0.00	1.53	3.56	2.03	1.27	3.56	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	284.27	3.21	1.41	1.80	1.92	1.41	1.28	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	245.25	1.19	6.65	1.90	1.19	1.66	6.65	3.80
frontal lobe, adult, pool1	10040-101F4	525.51	7.79	2.44	1.22	1.41	1.41	0.38	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	569.57	5.40	5.10	3.30	4.80	5.10	1.80	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	260.87	4.21	1.19	0.37	0.73	0.18	0.18	0.64
gall bladder, adult	10198-103E9	377.12	2.66	2.41	2.41	1.45	0.72	0.97	0.48
gamma delta positive T cells, donor1	11937-126A2	1111.83	11.81	1.61	3.22	2.15	2.15	2.15	2.15
gamma delta positive T cells, donor2	11938-126A3	1059.60	21.66	8.59	4.48	3.36	1.49	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	168.13	3.59	3.17	1.69	2.75	1.06	1.48	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	281.42	3.09	1.93	0.77	1.35	1.55	1.55	1.16
gastric cancer cell line:AZ521	10549-107H9	405.79	5.57	1.64	0.98	1.31	0.33	1.97	0.82
gastric cancer cell line:GSS	10560-108A2	122.64	4.58	3.66	1.83	3.66	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	402.54	7.31	3.20	2.51	2.51	2.51	1.60	0.69
giant cell carcinoma cell line:LU65	10487-107B1	122.66	1.15	3.10	0.69	0.69	0.34	0.23	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	524.01	18.19	2.52	1.68	1.68	1.96	0.56	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	356.92	5.99	7.48	4.49	1.50	2.00	10.97	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	129.30	1.16	0.32	0.00	0.32	0.42	0.84	1.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	146.20	1.54	1.12	0.98	0.28	0.42	0.84	0.84
glioblastoma cell line:T98G	10485-107A8	199.67	3.42	1.66	2.10	0.77	0.44	0.77	0.88
glioma cell line:GI-1	10413-106B8	292.58	4.98	1.76	2.34	0.59	0.59	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	780.66	4.37	8.02	20.41	10.93	8.02	5.10	0.00
globus pallidus, adult, donor10252	10161-103A8	951.72	4.39	15.38	25.14	6.10	16.60	17.57	1.95
globus pallidus, adult, donor10258	10367-105F7	776.34	1.37	10.95	15.06	9.58	17.80	13.69	1.37
globus pallidus, newborn, donor10223	10364-105F4	222.23	2.66	3.73	7.46	2.13	1.07	4.26	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	594.66	17.13	0.00	0.00	0.00	0.00	0.00	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	393.42	0.00	0.00	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	475.62	10.45	0.00	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	193.28	0.96	1.92	1.92	0.32	1.60	2.56	0.64
hIPS +CCl2, biol_rep1	14383-156B9	287.41	1.38	1.38	2.30	3.21	0.00	0.92	1.84
hIPS +CCl2, biol_rep2	14384-156C1	258.81	1.37	1.83	1.37	0.91	0.46	0.91	0.91
hIPS +CCl2, biol_rep3	14385-156C2	255.06	1.29	1.29	0.64	3.22	1.29	1.29	1.29
hIPS, biol_rep1	14380-156B6	330.58	0.00	1.44	1.44	2.87	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	281.21	2.74	0.69	3.43	2.06	0.69	1.37	0.69
hIPS, biol_rep3	14382-156B8	443.59	3.31	2.21	6.62	6.62	2.21	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	274.99	6.61	3.45	1.72	0.86	2.59	0.86	0.29
heart - mitral valve, adult	10205-103F7	465.79	2.39	11.06	7.47	3.89	3.59	8.97	1.20
heart - pulmonic valve, adult	10206-103F8	483.73	1.05	12.03	6.28	4.18	5.23	12.03	0.26
heart - tricuspid valve, adult	10207-103F9	372.19	1.67	22.48	21.65	5.00	0.83	23.31	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	314.45	3.67	1.22	2.45	1.84	2.24	1.84	0.41
heart, adult, diseased, donor1	10051-101G6	324.91	2.13	0.85	1.70	0.85	3.41	0.43	0.00
heart, adult, pool1	10016-101C7	128.79	0.46	1.38	0.69	0.00	0.46	0.46	0.23
heart, fetal, pool1	10046-101G1	425.40	1.44	2.57	0.92	0.92	0.92	0.31	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	218.13	1.54	2.47	1.85	2.78	1.85	6.48	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	665.94	4.76	3.57	4.76	1.19	0.00	5.95	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	315.47	2.21	2.54	1.77	1.22	1.66	2.54	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	328.68	2.31	2.06	1.58	0.36	1.21	1.58	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	339.24	2.53	1.62	1.31	1.01	1.82	0.61	0.40
hepatoma cell line:Li-7	10484-107A7	215.20	2.67	1.00	1.67	1.11	0.67	0.67	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	422.20	4.92	2.61	3.72	2.21	2.71	1.91	1.11
hippocampus - adult, donor10196	10169-103B7	719.21	13.25	14.19	22.71	15.14	8.52	15.14	1.89
hippocampus, adult, donor10252	10153-102I9	716.39	6.33	18.37	21.84	9.18	13.67	12.86	1.84
hippocampus, adult, donor10258	10374-105G5	452.14	6.47	3.49	4.98	5.48	1.99	1.99	0.00
hippocampus, newborn, donor10223	10363-105F3	228.76	6.70	3.88	3.17	4.93	1.41	3.17	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	582.27	7.32	0.61	4.27	2.44	3.66	1.83	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	288.84	3.34	3.14	1.18	1.96	0.59	0.59	2.55
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	311.78	3.81	0.76	1.78	1.78	0.76	1.52	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	458.99	0.56	1.69	5.07	7.33	2.82	2.82	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	447.48	3.10	8.78	5.94	7.49	7.75	3.10	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	536.01	1.52	3.04	8.73	3.80	4.56	3.04	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	564.05	1.46	5.26	10.80	6.42	4.38	4.09	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	481.27	3.02	9.91	7.11	7.97	2.59	2.15	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	495.90	1.25	4.17	6.67	4.59	5.00	5.84	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	490.40	4.03	8.76	4.74	2.60	0.95	0.71	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	412.56	2.57	8.04	5.63	3.05	3.05	2.73	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	497.57	5.39	6.06	2.02	2.02	0.00	0.00	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	320.48	2.97	3.29	2.66	1.72	1.41	0.78	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	333.59	3.44	5.90	2.95	0.98	3.44	0.98	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	486.12	3.49	1.75	3.49	3.49	0.00	1.75	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	601.94	1.34	9.74	5.73	6.30	4.39	2.67	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	580.85	0.87	9.59	4.36	6.54	3.92	5.23	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	724.65	0.50	3.50	8.00	10.99	6.50	4.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	407.87	1.13	12.06	9.80	6.97	6.03	4.71	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	391.06	0.91	16.37	4.09	7.73	2.27	3.18	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	402.19	1.57	10.65	15.04	10.02	5.01	6.26	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	404.66	2.94	10.12	6.21	6.04	3.59	2.61	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	404.98	3.77	10.45	4.35	4.06	2.03	1.16	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	370.96	2.69	5.68	11.36	7.77	3.59	2.99	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	343.63	2.77	1.85	2.03	1.66	1.11	0.92	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	329.22	3.14	4.28	2.57	0.86	2.00	0.86	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	451.18	7.35	2.86	3.67	4.49	2.45	2.45	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	491.15	3.87	4.58	1.76	1.76	2.11	1.06	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	469.09	1.58	5.38	1.58	2.22	3.80	1.58	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	459.98	2.42	2.72	6.05	3.93	4.24	2.12	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	427.14	0.52	15.00	2.59	5.17	2.07	2.07	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	461.60	1.33	19.92	5.98	7.31	3.98	1.33	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	396.60	1.80	3.33	7.95	3.33	3.59	3.59	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	338.99	2.56	7.41	2.56	1.28	1.79	1.79	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	466.45	3.79	11.36	3.03	2.27	4.54	1.51	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	349.84	0.67	3.02	8.07	4.70	1.68	2.69	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	349.46	4.59	4.35	0.97	1.69	2.17	0.72	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	430.95	3.57	0.45	4.01	5.35	0.89	2.23	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	375.61	2.44	1.95	3.41	4.39	1.46	1.46	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	553.47	0.31	4.28	2.75	1.83	3.06	0.92	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	4948.18	22.77	0.00	16.27	13.01	52.05	9.76	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	778.05	1.99	3.31	4.30	7.28	3.31	2.32	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	533.07	1.09	16.97	4.93	2.19	2.19	0.55	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	447.29	2.90	4.70	8.69	9.77	2.17	1.81	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	427.40	0.71	3.56	8.90	7.47	3.56	5.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	322.21	2.39	14.32	2.39	3.58	3.58	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	492.68	2.30	6.50	2.03	0.54	0.81	0.00	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	320.85	0.81	3.77	7.00	5.12	1.89	0.81	1.35
immature langerhans cells, donor1	11904-125F5	915.56	55.45	0.73	1.21	2.18	0.24	1.94	1.70
immature langerhans cells, donor2	11905-125F6	1112.15	42.78	17.43	5.54	8.71	6.34	11.88	2.38
insula, adult, pool1	10039-101F3	541.87	10.88	1.80	0.76	0.95	0.57	0.38	1.23
keratoacanthoma cell line:HKA-1	10791-110H8	273.12	1.30	1.63	3.58	0.98	1.95	3.90	0.00
kidney, adult, pool1	10017-101C8	263.94	0.90	1.20	1.60	0.50	1.40	1.20	0.40
kidney, fetal, pool1	10045-101F9	431.49	1.41	2.26	0.71	0.85	0.71	0.85	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	463.70	17.04	2.56	3.55	1.99	1.42	3.83	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	298.74	9.95	1.52	1.94	3.04	1.11	1.24	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	330.85	5.14	5.14	1.83	1.28	1.10	4.95	0.73
left atrium, adult, donor1	10079-102A7	131.31	0.00	1.09	2.18	0.54	1.63	2.72	0.00
left ventricle, adult, donor1	10078-102A6	120.85	0.00	0.51	1.52	1.01	2.02	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	375.12	5.47	1.64	2.19	0.27	1.92	9.03	1.92
leiomyoma cell line:10964C	10569-108B2	93.05	3.23	0.72	0.72	1.08	0.72	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	90.76	2.17	0.00	0.54	2.72	0.54	1.09	1.09
leiomyoma cell line:15425	10571-108B4	93.24	1.46	1.21	0.73	0.49	0.73	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	114.29	6.35	0.00	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	560.42	6.27	10.46	2.09	2.09	3.14	11.50	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	482.15	9.21	2.83	3.31	2.36	3.54	3.90	0.59
liposarcoma cell line:KMLS-1	10782-110G8	209.01	2.03	1.72	2.19	1.72	2.19	1.41	2.34
liposarcoma cell line:SW 872	10726-110A6	284.49	2.44	1.58	1.10	1.46	1.10	2.07	2.56
liver, adult, pool1	10018-101C9	223.97	1.30	0.97	0.16	0.32	0.00	0.00	0.49
liver, fetal, pool1	10086-102B5	186.26	0.00	1.88	0.00	0.94	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	575.57	4.23	14.29	19.98	6.71	8.60	10.21	0.87
locus coeruleus, adult, donor10252	10165-103B3	562.14	3.69	12.92	8.49	4.43	8.49	6.46	2.03
locus coeruleus, adult, donor10258	10375-105G6	287.50	3.95	6.49	9.31	7.05	6.21	9.03	1.69
locus coeruleus, newborn, donor10223	10362-105F2	334.39	2.94	5.05	11.36	5.89	2.52	3.79	1.68
lung adenocarcinoma cell line:A549	10499-107C4	218.80	2.08	0.83	1.25	0.55	0.28	1.25	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	363.32	0.69	1.38	2.07	0.69	2.07	0.69	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	303.57	3.16	2.90	0.53	0.66	0.92	2.24	0.40
lung, adult, pool1	10019-101D1	274.06	1.54	1.54	1.18	1.42	0.83	0.95	0.47
lung, fetal, donor1	10068-101I5	965.25	7.14	56.80	0.57	1.71	2.28	0.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	323.04	2.75	4.12	5.96	1.37	3.67	6.42	1.83
lymph node, adult, donor1	10077-102A5	214.91	1.89	0.95	2.84	0.47	0.47	1.42	0.95
lymphangiectasia cell line:DS-1	10727-110A7	278.79	2.41	1.53	3.51	2.19	1.10	2.41	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	365.39	3.92	0.91	1.06	0.30	0.75	1.06	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	691.49	17.84	1.70	1.70	0.85	1.70	1.70	5.95
mature adipocyte, donor1	12231-129F8	645.12	7.55	2.22	4.88	3.11	0.00	3.55	1.33
mature adipocyte, donor2	12232-129F9	441.83	6.64	0.83	2.49	1.45	1.25	1.25	0.62
mature adipocyte, donor3	12233-129G1	477.44	5.93	2.61	1.42	1.42	0.71	0.47	0.00
mature adipocyte, donor4	12234-129G2	599.87	6.05	1.84	2.63	1.58	0.26	1.32	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	371.45	3.10	0.24	0.71	0.24	0.95	0.71	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	691.48	16.92	5.64	7.90	3.38	9.02	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	742.43	7.91	9.38	18.21	3.13	10.48	6.25	2.02
medial frontal gyrus, adult, donor10258	10368-105F8	409.18	3.49	3.18	6.67	4.77	1.91	1.27	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	501.55	26.02	0.43	2.56	1.71	0.85	1.71	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	623.53	11.14	14.18	9.62	5.74	14.51	3.54	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	871.18	5.31	16.34	19.74	8.49	12.95	15.49	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	510.46	1.93	9.63	9.63	9.63	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	6918.44	57.41	100.48	28.71	0.00	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	246.23	11.49	1.79	2.87	5.38	0.72	3.59	0.00
medulla oblongata - adult, donor10196	10174-103C3	839.13	5.19	5.19	22.71	7.79	16.87	14.93	0.00
medulla oblongata, adult, donor10252	10155-103A2	624.01	2.63	8.82	11.15	3.87	7.43	7.12	1.08
medulla oblongata, adult, pool1	10038-101F2	516.37	5.14	2.53	1.63	1.14	0.73	0.24	1.96
medulla oblongata, newborn, donor10223	10361-105F1	253.44	3.47	3.12	6.25	4.51	0.69	2.78	2.08
medulloblastoma cell line:D283 Med	10838-111E1	1061.23	6.42	7.09	8.41	6.64	7.75	1.77	2.21
medulloblastoma cell line:ONS-76	10759-110E3	138.05	0.73	1.35	1.59	0.37	0.49	2.45	1.35
melanoma cell line:COLO 679	10514-107E1	246.53	4.89	1.72	1.44	1.29	0.86	1.87	0.43
melanoma cell line:G-361	10465-106H6	219.61	3.53	3.26	2.44	0.54	0.81	0.81	0.27
meningioma cell line:HKBMM	10691-109F7	190.67	2.35	3.80	2.89	2.35	1.09	2.71	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	771.01	3.52	15.86	9.69	9.69	10.57	9.69	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	548.52	3.63	10.37	6.74	5.70	4.15	2.07	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	188.11	1.99	2.92	0.15	0.15	0.31	0.00	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	138.34	4.36	4.00	0.18	0.55	0.55	0.18	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	129.61	2.90	4.14	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	149.33	17.14	4.21	0.14	0.42	0.84	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	139.61	4.43	2.31	0.19	0.19	0.19	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	215.16	3.47	1.39	0.00	0.00	0.00	0.00	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	146.75	4.46	4.12	0.00	0.51	0.86	0.17	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	147.34	4.83	3.68	1.15	0.23	0.58	0.00	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	158.77	5.57	2.25	0.40	0.00	0.13	0.13	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	131.80	4.32	4.05	0.27	0.54	0.27	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	163.60	2.99	2.99	0.28	0.28	0.00	0.00	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	215.40	1.98	1.98	1.32	1.65	1.32	1.98	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	158.85	2.77	3.18	0.42	0.55	0.14	0.14	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	133.00	1.40	1.05	1.05	0.70	1.05	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	158.64	2.04	4.08	0.20	0.41	1.63	0.00	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	166.79	2.88	2.16	0.72	0.36	0.00	0.36	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	130.55	4.34	3.62	0.21	0.21	0.31	0.31	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	150.93	4.33	0.91	1.14	0.46	0.00	0.46	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	229.08	4.20	6.71	0.42	0.42	0.00	0.00	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	182.16	4.48	5.68	0.60	0.45	0.90	0.15	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	163.51	4.20	3.33	0.18	0.53	0.35	0.00	0.96
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	246.30	2.21	1.47	2.58	0.74	1.47	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	156.81	4.29	1.14	2.00	1.72	0.57	0.00	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	192.82	3.37	0.84	1.68	0.84	1.26	0.84	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	132.43	1.83	1.37	0.91	0.46	0.00	0.00	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	129.68	1.02	1.53	0.77	0.26	0.26	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	134.80	0.52	0.52	2.36	0.52	0.79	0.26	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	140.80	0.92	1.54	0.92	0.00	1.54	0.00	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	128.74	0.24	0.94	0.24	0.00	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	141.14	0.34	1.02	2.03	0.68	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	131.65	0.79	1.18	1.18	0.79	1.18	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	124.65	0.46	0.00	0.00	1.39	0.93	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	170.45	0.58	0.58	0.87	0.58	0.58	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	151.26	1.34	1.12	0.89	0.00	0.67	0.45	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	164.88	0.96	1.92	1.20	0.48	0.24	0.48	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	175.27	2.20	0.73	2.20	0.73	2.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	143.33	1.01	1.34	0.34	0.67	0.67	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	140.83	1.23	1.23	0.00	0.82	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	165.38	0.86	1.29	0.86	1.29	1.29	0.43	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	117.58	0.00	8.20	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	139.45	0.00	5.16	0.00	0.00	5.16	5.16	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	162.07	0.97	2.27	1.95	1.30	0.00	0.00	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	157.14	0.00	5.82	0.00	2.91	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	159.39	1.60	2.13	0.53	1.07	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	122.67	0.00	0.00	1.64	1.64	2.45	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	172.98	1.17	3.11	2.33	3.11	0.78	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	125.92	0.00	6.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	169.88	0.99	2.98	0.99	2.98	0.00	1.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	133.48	0.00	0.00	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	186.19	2.37	4.15	3.56	2.37	2.37	1.19	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	170.58	0.00	3.66	2.44	0.00	4.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	0.00	27.05	0.00	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	152.01	0.63	5.07	1.90	0.63	2.53	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	174.18	0.34	10.00	7.24	4.48	2.41	2.76	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	154.74	0.00	10.75	4.30	6.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	135.72	0.00	3.99	7.98	3.99	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	179.08	0.00	0.00	3.44	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	152.39	0.00	4.07	7.74	6.52	0.81	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	155.71	0.79	2.38	6.36	4.77	1.59	2.38	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	126.16	0.59	4.13	4.72	2.36	3.54	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	175.18	0.94	2.49	3.43	3.74	1.25	1.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	171.09	4.01	5.35	5.35	6.68	4.01	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	149.02	0.00	2.37	1.18	5.91	2.37	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	169.49	2.57	5.14	2.57	5.14	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	154.89	1.38	3.44	3.44	3.44	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	147.95	0.99	0.49	4.45	3.46	1.48	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	107.66	0.00	3.36	3.36	5.61	2.24	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	157.11	1.27	2.54	3.82	3.82	5.09	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	94.70	0.40	0.40	0.81	1.61	0.40	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	111.21	2.18	0.00	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	79.82	1.27	2.53	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	149.29	0.00	6.68	2.43	0.61	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	194.32	0.00	4.52	0.00	13.56	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	150.73	0.00	4.12	3.29	5.77	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	144.45	0.79	3.97	2.18	0.79	1.19	0.79	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	135.31	1.30	3.24	4.54	3.24	1.62	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	127.33	0.00	4.07	12.22	2.04	2.04	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	208.13	0.00	0.00	0.00	0.00	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	241.67	2.13	1.18	1.18	1.65	0.47	1.65	2.60
mesothelioma cell line:ACC-MESO-4	10494-107B8	494.39	8.11	3.24	3.71	3.71	2.09	3.24	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	166.67	0.00	0.00	0.00	4.27	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	205.40	1.03	1.34	1.54	2.77	1.34	0.21	0.72
mesothelioma cell line:Mero-25	10850-111F4	124.37	0.91	1.13	0.68	0.45	1.36	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	113.19	0.00	0.73	0.24	0.49	0.73	0.24	0.73
mesothelioma cell line:Mero-48a	10852-111F6	110.94	0.66	1.77	0.89	0.89	0.89	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	242.83	1.58	2.63	2.37	4.47	2.10	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	205.97	1.70	2.38	2.21	1.87	1.36	1.36	1.02
mesothelioma cell line:Mero-84	10855-111F9	118.30	2.53	1.01	0.25	1.26	0.51	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	181.99	1.45	2.28	1.24	1.66	1.66	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	133.51	1.66	2.15	1.16	1.33	1.82	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	147.33	1.81	1.09	0.72	1.09	1.63	0.72	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	121.11	0.85	1.54	0.68	1.02	1.20	0.51	0.17
mesothelioma cell line:NCI-H28	10845-111E8	103.06	0.76	0.51	0.00	0.51	1.53	0.25	0.25
mesothelioma cell line:No36	10857-111G2	135.37	1.63	1.96	0.33	0.98	0.33	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	144.69	1.63	0.54	1.08	0.54	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	452.17	4.61	1.92	0.58	0.77	1.73	0.00	1.15
migratory langerhans cells, donor2	11902-125F3	269.02	3.30	0.73	0.61	0.37	0.24	0.12	0.24
migratory langerhans cells, donor3	11903-125F4	346.40	1.79	0.36	1.08	0.90	0.90	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	244.86	4.24	9.47	6.53	4.90	5.22	4.90	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	293.32	15.05	3.18	5.30	3.81	2.33	2.76	2.12
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	348.30	2.07	2.07	1.38	1.61	1.38	4.84	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	278.40	8.18	0.76	2.09	0.76	0.76	1.90	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	462.90	3.70	1.11	2.03	0.74	1.29	0.37	1.66
myeloma cell line:PCM6	10474-106I6	233.05	1.38	1.98	2.97	2.37	2.77	0.79	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	269.88	2.03	2.03	3.04	4.06	0.51	5.58	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	152.99	2.75	1.57	1.77	0.78	0.39	1.18	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	130.59	0.45	0.56	0.67	0.33	0.33	0.11	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	155.17	1.03	0.96	0.74	0.29	0.22	0.51	0.29
nasal epithelial cells, donor2	12227-129F4	234.04	4.42	0.55	0.55	1.10	0.55	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	704.91	2.30	4.14	5.75	5.52	2.30	3.91	0.92
neuroblastoma cell line:NB-1	10539-107G8	477.07	4.30	3.18	2.99	0.75	0.75	1.12	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	166.39	2.11	1.90	1.48	1.69	0.63	0.63	0.21
neuroblastoma cell line:NH-12	10555-107I6	622.97	3.73	7.45	4.47	3.54	4.10	2.98	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	535.89	7.83	6.41	10.91	7.83	6.88	9.73	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	323.89	2.38	2.06	6.97	4.43	3.96	2.06	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	385.41	2.82	6.44	11.07	6.24	4.03	5.03	1.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	411.34	1.27	1.27	1.91	0.64	0.64	8.26	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	144.26	1.86	1.06	1.33	0.00	0.80	1.60	1.33
neutrophil PMN, donor1	12133-128D9	669.37	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	903.09	13.28	0.00	0.00	0.00	0.00	0.00	26.56
neutrophil PMN, donor3	12141-128E8	947.06	18.94	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	632.85	3.55	8.12	3.38	1.69	4.74	1.01	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	149.69	0.80	0.80	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	239.81	5.45	3.53	6.73	5.77	2.56	0.96	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	173.42	2.36	5.52	4.99	2.89	0.79	1.58	0.00
nucleus accumbens, adult, pool1	10037-101F1	507.69	8.16	3.94	0.66	0.94	1.22	0.47	1.03
occipital cortex - adult, donor10196	10172-103C1	916.87	10.30	4.12	12.36	2.06	6.18	2.06	4.12
occipital cortex, adult, donor10252	10163-103B1	1043.40	4.83	25.49	53.14	13.69	22.54	35.42	2.42
occipital cortex, newborn, donor10223	10355-105E4	240.20	5.82	3.28	1.82	1.82	0.00	2.18	0.00
occipital lobe, adult, donor1	10076-102A4	410.92	5.51	8.13	9.18	2.62	4.72	6.04	0.00
occipital lobe, fetal, donor1	10073-102A1	475.44	3.43	5.15	9.87	7.29	8.58	9.01	1.72
occipital pole, adult, pool1	10036-101E9	374.65	5.20	1.66	0.47	0.71	0.63	0.39	0.63
olfactory region, adult	10195-103E6	474.57	4.97	6.88	12.99	3.82	5.54	6.11	0.38
optic nerve, donor1	10277-104E7	1158.61	4.00	24.01	34.02	6.00	4.00	30.02	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	250.94	3.08	0.80	0.57	0.57	0.34	0.23	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	374.38	3.71	2.89	2.61	0.69	0.69	0.96	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	417.55	5.42	3.05	2.71	2.20	3.05	3.89	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	283.34	5.78	3.00	1.16	1.04	1.16	0.81	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	192.25	0.88	1.47	0.59	1.18	1.47	0.88	2.06
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	492.39	1.87	5.61	3.74	0.93	0.00	7.47	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	500.25	7.21	2.54	1.70	2.76	2.54	0.64	0.85
ovary, adult, pool1	10020-101D2	264.76	0.44	0.44	0.79	0.17	0.17	0.79	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	197.62	2.20	0.73	5.50	2.20	1.83	7.52	0.73
pancreas, adult, donor1	10049-101G4	198.47	1.88	0.94	5.64	1.88	0.94	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	476.33	7.55	3.91	1.96	1.68	2.24	5.87	3.63
papillary adenocarcinoma cell line:8505C	10437-106E5	213.62	6.13	1.36	1.53	1.02	0.68	0.68	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	311.13	4.14	0.66	1.49	0.83	0.99	0.33	0.83
paracentral gyrus, adult, pool1	10035-101E8	435.74	8.42	2.11	1.46	0.82	0.46	0.18	0.73
parietal cortex, adult, donor10258	10373-105G4	375.08	5.87	2.20	9.54	9.54	2.20	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	739.22	7.52	12.23	18.81	9.40	5.64	4.70	0.00
parietal lobe, adult, donor10252	10157-103A4	742.24	5.13	17.39	18.24	4.56	8.27	5.42	0.57
parietal lobe, adult, pool1	10034-101E7	454.34	6.70	2.38	1.06	0.70	1.23	0.44	0.79
parietal lobe, fetal, donor1	10072-101I9	556.68	2.91	5.82	2.91	12.61	5.82	5.82	0.97
parietal lobe, newborn, donor10223	10356-105E5	247.12	7.48	0.37	4.49	0.75	1.12	5.23	0.00
parotid gland, adult	10199-103F1	176.37	0.62	3.70	3.08	0.62	0.62	1.85	0.62
penis, adult	10200-103F2	395.85	2.15	10.74	5.91	6.98	5.91	6.98	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	62.47	1.49	1.49	1.12	1.30	1.12	0.93	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	347.34	4.08	1.75	5.68	3.50	3.79	5.68	1.60
pineal gland - adult, donor10196	10179-103C8	985.60	32.90	12.26	41.28	14.84	11.61	12.90	1.94
pineal gland, adult, donor10252	10160-103A7	1373.34	20.14	6.51	11.84	10.66	13.62	2.96	4.15
pineal gland, adult, donor10258	10377-105G8	500.41	4.39	5.02	5.64	10.03	5.02	0.63	1.25
pituitary gland - adult, donor10196	10180-103C9	1329.51	17.20	7.08	5.06	13.15	18.21	3.04	2.02
pituitary gland, adult, donor10252	10162-103A9	1901.78	6.78	13.03	4.17	8.34	13.55	6.25	2.08
pituitary gland, adult, donor10258	10378-105G9	586.51	1.70	6.81	9.36	8.51	10.21	3.40	0.85
placenta, adult, pool1	10021-101D3	410.66	7.31	2.37	3.55	2.80	0.97	3.12	1.18
plasma cell leukemia cell line:ARH-77	10840-111E3	409.73	7.02	1.59	1.46	2.25	1.99	1.46	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	273.46	2.80	0.62	2.33	0.93	0.93	1.40	0.00
pons, adult, pool1	10033-101E6	437.39	8.18	2.15	1.03	1.03	1.20	0.34	1.29
postcentral gyrus, adult, pool1	10032-101E5	476.76	6.54	1.83	0.52	1.31	1.05	0.70	0.96
promyelocytes/myelocytes PMC, donor1	12132-128D8	382.73	20.91	0.00	0.00	0.00	0.00	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	457.17	11.02	5.51	5.51	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	352.07	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	446.16	14.86	3.35	4.37	3.35	2.77	1.75	2.04
prostate cancer cell line:PC-3	10439-106E7	596.60	5.45	7.99	6.72	3.81	4.36	9.44	2.18
prostate, adult, pool1	10022-101D4	251.22	0.54	2.18	1.27	1.00	0.73	0.91	1.00
putamen, adult, donor10196	10176-103C5	650.36	8.97	5.43	9.68	4.25	5.67	3.30	0.71
putamen, adult, donor10252	10152-102I8	733.31	0.00	3.92	15.69	5.88	3.92	0.00	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	264.46	0.00	3.28	1.09	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	281.48	3.87	1.69	3.62	3.14	1.45	0.72	0.48
putamen, newborn, donor10223	10365-105F5	519.52	13.49	3.00	7.50	2.25	3.00	4.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	309.26	2.33	1.45	3.20	1.75	0.29	3.78	0.29
rectum, fetal, donor1	10067-101I4	662.11	1.39	16.69	26.43	5.56	2.78	30.60	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	146.91	2.33	0.85	0.00	0.42	0.21	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	92.78	0.83	4.56	4.14	1.66	2.90	1.24	0.41
retina, adult, pool1	10030-101E3	664.78	3.28	4.87	2.39	1.29	2.19	0.99	0.89
retinoblastoma cell line:Y79	10475-106I7	628.72	3.90	7.53	9.61	6.24	3.64	3.38	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	388.89	7.50	3.81	5.16	3.32	3.57	6.39	2.09
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	396.77	1.12	1.97	0.56	0.56	0.84	2.53	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	312.99	11.37	1.52	0.00	0.00	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	282.60	3.24	3.08	2.43	1.29	1.78	2.27	0.97
salivary acinar cells, donor2	11772-123I8	357.44	1.93	4.68	2.62	2.75	3.03	2.20	1.10
salivary acinar cells, donor3	11773-123I9	564.73	2.65	3.31	3.97	1.99	1.99	3.31	1.32
salivary gland, adult, pool1	10093-102C3	415.24	1.72	28.03	1.14	0.00	0.57	0.00	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	193.16	3.88	0.67	0.25	0.67	0.25	0.08	1.10
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	220.88	2.94	0.94	0.82	0.94	0.71	0.82	1.41
seminal vesicle, adult	10201-103F3	604.73	6.35	30.69	16.40	14.28	6.35	12.70	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	591.76	9.72	6.32	8.02	5.10	3.89	3.64	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	433.31	10.07	2.77	2.01	1.26	1.51	0.50	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	130.46	2.01	0.00	0.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	293.22	6.31	3.49	2.15	1.61	1.61	0.67	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	235.53	3.09	2.98	1.55	1.33	0.99	0.22	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	192.12	1.81	2.97	1.42	1.42	0.39	0.90	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	567.47	1.42	4.97	1.42	1.42	4.97	9.93	0.00
skeletal muscle, adult, pool1	10023-101D5	176.79	0.84	0.48	0.96	0.84	0.12	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	106.53	1.01	0.00	0.00	0.00	1.01	2.01	1.01
skin, adult, donor1	10074-102A2	176.42	0.00	0.00	0.00	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	452.59	1.26	1.26	5.05	6.31	4.42	4.42	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	480.61	3.67	4.00	7.67	6.34	4.67	6.67	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	630.41	5.99	4.41	6.93	4.10	5.04	3.78	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	385.69	9.25	3.28	1.54	2.12	2.89	2.31	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	423.61	3.46	2.64	1.48	1.48	0.99	1.48	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	501.85	2.73	4.18	3.38	4.34	5.47	3.06	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	387.89	5.01	2.40	2.18	0.87	1.09	1.96	1.53
small intestine, adult, pool1	10024-101D6	582.16	3.58	2.39	3.22	2.03	1.43	1.07	1.55
small intestine, fetal, donor1	10064-101I1	321.37	2.21	0.98	2.46	3.44	3.44	2.95	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	239.52	6.15	3.59	5.13	1.54	1.03	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	390.01	1.55	1.55	1.81	2.33	2.33	3.88	0.52
somatostatinoma cell line:QGP-1	10781-110G7	201.55	1.61	0.54	1.07	1.34	0.27	3.48	0.00
spinal cord - adult, donor10196	10181-103D1	660.00	3.67	2.98	13.08	3.67	11.01	5.96	0.69
spinal cord, adult, donor10252	10159-103A6	740.44	4.34	5.52	5.52	5.91	5.52	6.70	0.00
spinal cord, adult, donor10258	10369-105F9	863.36	6.23	11.07	15.91	16.60	4.15	6.23	0.00
spinal cord, fetal, donor1	10056-101H2	476.28	5.49	3.05	14.64	4.27	4.88	6.71	2.44
spinal cord, newborn, donor10223	10359-105E8	547.84	4.59	2.76	5.97	3.67	2.30	4.59	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	128.59	1.19	0.90	0.60	0.30	0.45	1.49	0.75
spleen, adult, pool1	10025-101D7	321.81	0.33	1.43	1.43	1.43	0.44	0.55	1.21
spleen, fetal, pool1	10044-101F8	453.77	3.18	2.54	0.72	0.87	0.48	0.32	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	248.22	1.24	1.35	1.04	0.62	1.04	0.41	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	438.42	4.18	3.80	5.70	3.80	1.52	9.30	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	421.44	6.99	3.15	3.49	3.84	4.89	1.75	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	403.83	8.99	2.74	0.78	1.56	0.78	2.35	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	495.03	4.61	2.93	2.03	2.36	2.25	1.80	2.81
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	106.75	1.69	0.85	0.85	1.69	0.42	0.85	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	244.11	0.85	2.54	0.85	0.85	0.85	0.00	0.42
stomach, fetal, donor1	10062-101H8	881.08	3.20	4.27	5.34	1.07	3.20	10.68	6.41
submaxillary gland, adult	10202-103F4	417.01	1.71	11.96	6.27	4.56	3.99	3.42	1.14
substantia nigra - adult, donor10196	10178-103C7	1791.05	54.27	597.02	922.66	814.11	488.47	162.82	0.00
substantia nigra, adult, donor10252	10158-103A5	824.18	3.74	16.62	13.71	6.65	16.82	7.06	0.62
substantia nigra, adult, donor10258	10371-105G2	470.70	4.14	5.69	6.21	6.21	2.07	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	241.65	0.71	7.07	9.19	7.07	2.83	9.89	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	284.98	2.29	0.69	1.15	0.92	1.38	1.38	1.15
temporal lobe, adult, pool1	10031-101E4	395.37	5.51	1.36	0.59	0.51	0.51	0.42	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	521.38	0.00	2.85	9.97	4.27	4.27	4.27	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	355.59	3.52	10.11	4.40	5.27	2.64	4.40	2.64
tenocyte, donor1	11763-123H8	165.47	1.75	4.19	2.44	1.40	2.79	0.70	0.00
tenocyte, donor2	11765-123I1	207.54	0.00	4.20	3.82	5.72	3.43	1.91	0.38
tenocyte, donor3	11768-123I4	167.54	1.48	6.67	4.45	3.71	1.85	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	247.46	3.06	1.19	1.36	0.51	1.36	0.68	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	456.28	3.85	3.55	4.32	3.24	6.78	2.77	2.77
teratocarcinoma cell line:PA-1	10807-111A6	341.57	1.39	3.56	3.10	3.10	2.17	3.56	3.72
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	216.19	3.30	1.27	1.27	0.89	1.02	2.16	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	171.31	0.38	1.13	1.13	1.51	1.13	2.27	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	174.94	1.53	3.49	0.44	0.44	0.98	0.22	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	244.28	1.95	3.26	1.95	0.98	1.63	4.23	0.98
testis, adult, pool1	10026-101D8	229.67	1.40	1.07	1.40	0.64	0.21	0.86	2.58
testis, adult, pool2	10096-102C6	422.67	4.06	6.77	5.86	5.41	3.61	2.71	15.79
thalamus - adult, donor10196	10168-103B6	843.45	2.21	17.66	20.98	7.73	19.87	6.62	1.10
thalamus, adult, donor10252	10154-103A1	763.29	3.59	16.41	11.56	6.25	12.82	7.03	1.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	719.00	7.70	15.40	6.16	6.16	1.54	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	239.95	1.48	3.62	10.70	7.08	2.80	5.11	0.49
thalamus, newborn, donor10223	10366-105F6	328.51	5.18	4.03	6.33	4.60	1.15	6.90	0.58
throat, adult	10209-103G2	406.46	2.75	8.99	2.75	2.00	3.99	3.50	1.50
throat, fetal, donor1	10061-101H7	515.87	1.52	5.18	22.85	5.48	4.27	11.27	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	420.12	1.59	7.75	5.96	3.78	2.78	2.58	0.00
thymus, adult, pool1	10027-101D9	391.00	1.99	0.20	0.80	0.50	0.60	0.80	0.20
thymus, fetal, pool1	10043-101F7	925.69	2.49	4.36	2.60	2.39	1.66	0.83	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	271.24	1.86	3.32	1.20	1.33	1.46	0.66	1.86
thyroid carcinoma cell line:TCO-1	10783-110G9	476.76	6.29	5.73	9.64	5.87	4.75	7.40	2.10
thyroid, adult, pool1	10028-101E1	219.01	0.65	1.96	2.15	1.40	0.37	1.12	0.19
thyroid, fetal, donor1	10060-101H6	632.53	3.69	6.59	18.98	7.38	5.80	9.76	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	853.05	3.08	12.32	27.72	3.08	9.24	30.80	3.08
tongue, adult	10203-103F5	341.66	5.12	2.56	4.42	2.56	2.09	1.40	1.40
tongue, fetal, donor1	10059-101H5	273.50	1.97	0.00	1.58	0.00	2.36	3.55	0.00
tonsil, adult, pool1	10047-101G2	635.01	3.61	2.70	1.70	1.60	0.70	0.70	1.00
trachea, adult, pool1	10029-101E2	219.87	1.47	1.39	1.06	1.06	0.08	0.82	0.98
trachea, fetal, donor1	10058-101H4	419.32	0.77	5.00	10.77	5.39	4.23	8.08	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	179.62	2.13	1.42	3.19	0.71	2.13	2.48	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	302.43	5.57	1.32	1.32	1.11	0.81	1.01	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	498.42	7.05	4.54	6.42	4.39	4.23	2.82	2.19
tridermal teratoma cell line:HGRT	10694-109G1	353.87	13.32	1.90	3.81	0.00	0.00	9.51	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	194.70	1.69	0.85	1.35	0.93	1.27	1.19	0.42
umbilical cord, fetal, donor1	10057-101H3	308.80	4.17	2.09	4.17	2.09	2.09	4.17	0.00
uterus, adult, pool1	10100-102D1	544.99	0.68	21.50	0.68	0.34	1.19	0.17	0.68
uterus, fetal, donor1	10055-101H1	404.94	2.05	5.12	18.94	2.56	4.10	7.17	1.02
vagina, adult	10204-103F6	241.68	0.65	1.94	2.58	0.65	0.00	0.65	0.00
vein, adult	10191-103E2	354.88	1.53	5.26	4.38	3.07	1.97	1.97	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	276.65	2.94	2.94	2.14	1.07	1.34	0.53	0.53